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ABSTRACT 
Human studies on the response of muscle to contusion injury are limited, 
probably due to the large variability in injury severity and the non-specificity of 
clinical symptoms reported.  To circumvent this problem, several experimental 
animal models have been designed to study muscle damage and regeneration 
after contusion injuries.  However, the majority of techniques currently used to 
induce contusion injury are very invasive and therefore not optimal.  Furthermore, 
published studies regarding clinical treatment of such injuries are limited.  The 
main aims of this study were therefore: a) to establish and characterise an in vivo 
model of non-invasive contusion injury, and b) to assess the effect of pre-injury 
chronic administration of the antioxidant supplement Oxiprovin™ - a natural 
grape seed extract (GSE) - on skeletal muscle recovery after experimentally-
induced injury.   
 
Two groups of male Wistar rats were subjected to 14 days of oral administration 
of isovolaemic placebo (sterile isotonic saline) or GSE (20 mg/kg/day) prior to 
induced contusion.  Contusion injury was induced with the mass-drop technique, 
and recovery parameters assessed for up to 14 days post-injury.  Placebo-
treated rats on average exhibited a 56 % higher creatine kinase (CK) activity 
when compared to the GSE-treated rats when area under the curve (AUC) was 
calculated for 14 days post-injury (p < 0.001).  In the placebo group, plasma 
oxygen radical absorbance capacity (ORAC) was unchanged over time, but 
muscle ORAC was significantly increased by day 7 post-injury (p < 0.001).  In the 
GSE group, a significant decrease in both plasma (p < 0.01) and muscle ORAC 
(p < 0.001) was evident 4 hr after injury, followed by a significant increase by day 
3 (p < 0.05 and p < 0.001 respectively).  CD34+ satellite cell (SC) numbers 
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(quiescent and activated) peaked earlier in GSE-treated rats when compared to 
placebo-treated rats (4 hours vs. day 7 post-injury). Total satellite cell number 
(CD56+) also peaked earlier in GSE-treated rats than in placebo-treated rats (4 
hours vs. 3 days post-injury), while M-cadherin+ SC numbers (quiescent, 
activated or proliferating) in both treatment groups were significantly increased 4 
hours post-injury (p < 0.001), but more so in the placebo group.  In GSE-treated 
rats when compared to placebo-treated rats, newly generated muscle fibres 
(displaying central nuclei and MHCf+) both appeared (day 3 vs. day 7 post-injury) 
and peaked in number (day 3 vs. day 7 post-injury; increase from baseline p < 
0.001 for both) earlier.     
 
The results of this study demonstrate that we have successfully established an in 
vivo model for non-invasive contusion injury in rats. Furthermore, we have shown 
that Oxiprovin™: a) increased the ability to scavenge reactive species generated 
after injury and b) resulted in the activation of satellite cells and formation of 
newly generated muscle fibres at an earlier time point, thus accelerating the 
recovery of skeletal muscle after a standardised contusion injury.  
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OPSOMMING 
Eksperimente aangaande die reaksie van spier op kneusings in mense is beperk, 
waarskynlik as gevolg van die groot verskeidenheid simptome wat mag voorkom 
en die verskille in die ernstigheid van beserings.  Ten einde hierdie problem te 
oorbrug, is verskeie eksperimentele diermodelle opgestel om kneusings en die 
herstel van spier daarna te ondersoek.  Die tegnieke wat grootendeels vandag 
gebruik word om kneusings te veroorsaak, maak inbraak op die spier deur die 
spier te ontbloot voor besering, en is dus nie ideaal nie.  Daar is ook nie baie 
bewyse aangaande die mees geskikte manier om so ‘n besering klinies te 
behandel nie.  Die doel van hierdie studie was dus om: a) ‘n in vivo model van 
kneusings op te stel en te omskryf, en b) die effek van chroniese toediening van 
die antioksidant Oxiprovin™ - ‘n natuurlike druifsaad ekstrak (DSE) – op die 
herstel van skeletspier na ‘n kneusing te ondersoek. 
 
Twee groepe manlike Wistar rotte is onderwerp aan mondelikse toediening van 
isovolemiese plasebo (steriele isotoniese soutoplossing) of DSE (20 mg/kg/dag) 
vir ‘n tydperk van 14 dae voor kneusing.  Kneusing is geïnduseer met die “mass-
drop” tegniek, en parameters van herstel is ondersoek tot en met 14 dae na 
besering.  Plasebo-behandelde rotte het gemiddeld 56 % hoër kreatien kinase 
(KK) aktiwiteit in vergelyking met DSE-behandelde rotte (p < 0.001), toe die 
oppervlak onder die kurwe (OOK) tot en met 14 dae na besering bereken is.  
Geen verskil oor tyd is in die plasebo groep opgemerk toe plasma suurstof 
radikaal absorpsie kapasiteit (SRAK) bepaal is nie, maar ‘n betekenisvolle 
toename in spier SRAK teen dag 7 (p < 0.001) is waargeneem.  ‘n Betekenisvolle 
afname in beide plasma (p < 0.01) en spier (p < 0.001) SRAK van die DSE is 
teen 4 hr waargeneem, gevolg deur ‘n betekenisvolle toename teen dag 3 na 
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besering (p < 0.05 en p < 0.001 onderskeidelik).  Die aantal CD34+ satelliet selle 
(SS – rustend en geaktiveerd) het beduidend vroeër in die DSE groep gestyg in 
vergelyking met die plasebo groep (4 uur vs. 7 dae na besering).  Die totale 
aantal SS (CD56+) het ook vroeër in die DSE-behandelde rotte as die plasebo-
behandelde rotte gestyg (4 uur vs. 3 dae na besering), terwyl die aantal M-
cadherin+ SS  (rustend, geaktiveerd of prolifererend) betenisvol gestyg het in 
beide groepe teen 4 uur (p < 0.001) na besering, maar hoër in die plasebo groep 
was.  Die aantal nuutgevormde spiervesels (met sentraal geleë nukleï en MHCf+) 
het beide vroeër verskyn en gepiek in die DSE-behandelde rotte in vergelyking 
met die plasebo-behandelde rotte (dag 3 vs. dag 7 na besering). 
  
Die resultate van hierdie studie dui aan dat ons instaat was om ‘n in vivo model 
van nie-indringende kneusing in rotte op te stel.  Verder, het ons ook bewys dat 
Oxiprovin™ toediening die vermoë verleen het om: a) reaktiewe spesies wat na 
beserings gevorm word, meer doeltreffend te verwyder en b) satelliet selle vroeër 
te aktiveer en die vorming van nuwe skeletspiervesels te vervroeg, om sodoende 
die herstel van skeletspier na ‘n gestandardiseerde kneusing vinniger te 
bewerkstellig.  
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CHAPTER 1:  LITERATURE REVIEW 
 
1.1  Introduction 
According to published studies in the United states of America [1-3], contusion and 
strain injuries account for approximately 90% of all sports-related injuries and 
contusion caused by a blunt, non-penetrating object is the most frequent type of 
injury [4] reported in athletes – contributing up to 60% of all reported injuries.  Muscle 
groups in the arms, hands, legs, feet and buttocks are most commonly affected [5], 
and apart from the expected mechanical damage to muscle cells themselves, at a 
microstructural level, skeletal muscle contusion injury involves capillary rupture and 
infiltrative bleeding, oedema, and inflammation.  These changes may lead to 
haematoma (blood clot) formation and can cause compartment syndrome in areas 
where volumes are limited by fascial planes [6].  This phenomenon is characterised 
by severe pain.  In addition, oxygen and nutrients are prevented from reaching nerve 
and muscle cells [5, 6] due to the disrupted blood supply, thus exacerbating the 
extent of injury and the ability to resolve the injury.  The magnitude of the 
inflammatory response and the time it takes for muscle to heal largely depends on 
the severity of the injury and the degree of vascularisation of the tissue [7].   
 
Interactions between the immune system and skeletal muscle may play a significant 
role in modulating the course of both the muscle injury and the repair process after a 
contusion injury.  As a result of muscle injury and capillary rupture, mast cells 
present within the damaged area release histamine, which causes an increase in 
blood flow to the site of injury, thereby allowing more blood-borne inflammatory cells 
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to gain direct access to the site of injury [8].  In the early acute phase following an 
injury to skeletal muscle, neutrophils are the most abundant immune cells at the 
injury site, but within the first day neutrophil numbers start to decline and the number 
of macrophages increases [9].   However, neutrophils remain functionally active and 
their numbers elevated from baseline at the site of injury for approximately 5 days, 
after which their activity gradually returns to pre-injury levels.  Although the function 
of neutrophils in response to muscle injury is well described (see later), the specific 
roles for macrophages in vivo are poorly understood [10, 11].  In addition, although it 
is generally accepted that cytokines (secreted by neutrophils and macrophages) 
control the events following an injury, the exact role players and their respective 
contributions remain unclear, since e.g. damaged skeletal muscle may itself also 
produce cytokines and the roles of particular cytokines are difficult to unravel.   
 
Satellite cells, a population of mononucleated progenitor cells specific to skeletal 
muscle, also play an important role after injury, in replacing or repairing the damaged 
muscle fibres.  Satellite cells are located on the surface of myofibres but beneath the 
basement membrane [12-14].  When the muscle is injured, satellite cells become 
activated and start to proliferate, differentiate and fuse either with other myoblasts, or 
with damaged muscle fibres [15, 16].  In mature skeletal muscle, satellite cells are 
normally quiescent, but are activated not only in response to muscle damage, but 
growth and hypertrophy as well [14].  The most reliable way to identify satellite cells 
is on the basis of their position using various forms of microscopy with or without the 
use of antibodies raised against proteins expressed by the satellite cells themselves, 
or against adjacent structural proteins.  Therefore much interest has been placed on 
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antibodies to identify specific proteins in quiescent and activated satellite cells in vivo 
[17, 18].   
 
While the clinical aspects of a contusion injury have been well documented in the 
sports-related clinical literature, symptoms of contusion injuries are often non-
specific and include soreness, pain with active and passive motion, and a limited 
range of motion [19].  Despite occurrence of these debilitating symptoms, the large 
variability in the severity of injury and the multiple underlying processes complicate 
research efforts, so that an universally accepted treatment modality is still elusive [6, 
20].  One way of treating skeletal muscle contusion injury could be through the diet.  
Diets rich in fruits and vegetables supply antioxidants [21], which can then convey 
protection against reactive oxygen species (ROS) generated in both the skeletal 
muscle and other cell types after sustaining a contusion injury [22].  However, before 
attempting to find a remedy for this problem, a better understanding of the 
mechanisms and role players involved in the healing of muscle after injury is 
required, as well as a reproducible model of contusion injury in which all these 
factors can be fully researched. 
 
 
1.2  Skeletal muscle 
1.2.1  Introduction 
Skeletal muscle, a complex structure consisting of muscle cells, organized networks 
of nerves and blood vessels, and an extracellular connective-tissue matrix, 
represents the largest tissue mass in the body, constituting approximately 40 to 45% 
of total body weight in males (healthy young male adults,weight: 60-80 kg; age: 20-
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35 yr) [23].  This framework is necessary to produce joint movement and locomotion, 
for postural behaviour as well as for breathing [24].  However, skeletal muscle is 
susceptible to injury, which results in the production of free radicals by neutrophils 
and macrophages [25], and if not repaired properly, a loss of muscle mass, 
locomotive deficiency and in the worst cases lethality may occur [24].  One possible 
reason for the body not repairing itself completely, might be inadequate intake of 
essential vitamins and minerals [26].  However when the body has an adequate 
intake of supplements, the body repairs itself after injury, through a process known 
as skeletal muscle regeneration.  This process is finely regulated by various cellular 
responses, and supports skeletal muscle following injury to prevent any of the above 
mentioned detrimental outcomes [27].  
 
1.2.2  Basic structure and function 
Muscle cells are in many ways similar to any other bodily cell, but because skeletal 
muscle cell function is highly specialised to produce force and movement [28], the 
cellular components responsible for maintaining this function must also be highly 
specialised [29].  
 
A cross section of muscle at various areas through the basic structures of the muscle 
indicates the three types of connective tissue which surrounds the muscle (see figure 
1.1).  Each muscle is surrounded by a connective tissue sheath, the epimysium, 
which is surrounded by fascia, separating the muscles from one another.  Portions of 
the epimysium project inward to divide the muscle into compartments, each 
compartment containing a bundle of muscle fibres called a fasciculus.   The 
fasciculus is surrounded by a layer of connective tissue called the perimysium  
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Figure 1.1: Schematic representation of skeletal muscle showing the gross 
components. Modified from Martini (1998) [29]. 
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containing muscle fibres, each of which is a single cell surrounded by the 
endomysium.  Muscle fibres (groups of muscle cells, also knows as myofibres) have 
an elongated, cylindrical shape, and are multinucleated.  The nuclei of these 
myofibres (myonuclei) are located just under the plasma membrane, with the central 
part of the muscle fibre free of nuclei [29] (Figure 1.1).  Scattered satellite cells lie 
between the endomysium and the muscle fibres and function to repair damaged 
muscle tissue (discussed in detail later) [14]. 
 
1.2.3  Skeletal muscle fibre types 
The existence of different fibre types in skeletal muscle is readily apparent and has 
long been recognized by the development of highly sensitive enzyme assays.  One 
of these assays make use of adenosine triphosphate (ATP) utilizing enzymes that 
operate during contraction and relaxation [30, 31].  The muscle fibres are extremely 
adaptable, and although the fibre type distribution is genetically determined at birth, 
an appropriate training programme will have a major effect on the metabolic potential 
of the muscle, irrespective of the fibre types present [32].   
 
Myosin is the largest and hence the most abundant contractile molecule in 
mammalian skeletal muscles. This polymorphic molecule exists in various different 
isoforms.  These isoforms can be separated based on their electrophoretic mobility 
or, based on histochemical staining using the myosin adenosine triphosphatase 
(mATPase) assay into various myosin heavy chain (MHC) isoforms. In rodents, the 
MHC I is expressed in type I fibres (slow twitch-fatigue resistant), MHC IIa in type IIA 
(fast twitch-fatigue resistant), MHC IIb in type IIB (fast twitch-fatiguable) and MHC IIx 
or d in type IIX fibres (fast twitch-fatiguable) [33].  Adult human skeletal muscle on 
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the other hand appears to express each of these muscle isoforms, with the exception 
of the fast type IIb MHC isoform.  Although Weiss et al. (1999) recently cloned the 
human fast type IIb gene, it is expressed in selected muscle groups [34].  The 
biochemical characteristics of the three major fibre types, type I, IIA and IIB, are 
summarised in Table 1.1. 
 
Table 1.1: Biochemical characteristics of human muscle fibre types.   
The relative metabolic characteristics of type I, type IIA and IIB fibres are indicated.  
Adapted from Seiler (1996) [35].  
 
Characteristic Type I Type IIA Type IIB 
Nomenclature Slow 
Red 
Fatigue resistant 
Oxidative 
 
Fast 
White 
Fatigue resistant 
Oxidative/glycolytic 
Fast 
White 
Fatiguable 
Glycolytic 
Capillary density High 
 
Intermediate Low 
Mitochondrial density High 
 
High Low 
Oxidative capacity High 
 
High Low 
Glycolytic capacity Low 
 
High High 
Activity used for Aerobic (long term) 
 
Aerobic (short term) Anaerobic (short 
term) 
Force production Low 
 
High Very high 
Major storage fuel Triglycerides 
 
Glycogen Glycogen 
 
 
Depending on the kind of contractile activity the different skeletal muscles are 
required to perform, the fibres are able to respond to altered demand by undergoing 
a series of structural and biochemical adaptations, resulting in switching from one 
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fibre type to another [36].  Conversion from type IIB to IIA, and IIA to IIB has been 
observed in humans in response to various stimuli.  Type IIB conversion to IIA has 
been observed in response to different exercise regimes [37-40], whereas 
conversion from type IIA to IIB took place after detraining or denervation [41, 42].  
Conversion from type I to IIX has also been shown to occur in human muscle after 
denervation [41], but this switch in fibre type took approximately 20 months, 
indicating that conversion between fast-twitch and slow-twitch fibres might involve 
more extreme adaptations.  The mechanism for conversion from type II to I fibres still 
remains elusive, due in part to the inconsistency in results [43-48] and in part 
because the genes for the MHC I protein are situated on a different chromosome, 
while those for MHC IIa and b are close together on a single chromosome so that 
control of switching is a single process [49].  It has also been shown that hybrid 
fibres (containing more than one MHC isoform) exist in human, rat and dog muscle 
and are formed in response to exercise [50-52].  Putman et al. (2004) proposed that 
hybrid fibres might reflect fibres that are in the process of expressing either the one 
or the other MHC isoform whilst the previously expressed protein is still present [50].  
On the other hand, Stephenson (2001) and Wu et al. (2000) are of the notion that the 
occurrence of hybrid fibres is an adaptation involving expression of both isoforms in 
order to provide the muscle with a wider variety of functional properties [53, 54].   
 
Type I fibres are small diameter blood cells with a red colour that contain relatively 
slow acting myosin ATPases and hence contract slowly.  The red colour is due to the 
presence of myoglobin, an intracellular respiratory pigment, capable of binding 
oxygen and only releasing it at very low partial pressure (as found in the proximity of 
the mitochondria) [55, 56].  Type I fibres have numerous mitochondria, mostly 
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located close to the periphery of the fibre, near the blood capillaries which provide a 
rich supply of oxygen and nutrients [57].  These fibres possess a high capacity for 
oxidative metabolism, are extremely fatigue resistant and specialised for the 
performance of repeated contractions over prolonged periods [55, 56].   
 
Type IIB fibres are much paler than type I, because they contain little myoglobin.  
They possess more rapidly acting myosin ATPases and so their contraction (and 
relaxation) time is relatively fast.  They have fewer mitochondria, a poorer capillary 
supply [57], but greater glycogen and phosphocreatine stores compared to the type I 
fibres.  High activities of glycogenolytic and glycolytic enzymes cause type IIB fibres 
to have a high capacity for rapid (but relatively short-lived) ATP production in the 
absence of oxygen (anaerobic capacity).  As a result lactate can accumulate quickly 
in these fibres.  They also fatigue rapidly.  Hence, these fibres are best suited for 
delivering more rapid, powerful contractions for brief periods.  The metabolic 
characteristics of type IIA fibres lie between the extreme properties of the other two 
fibre types.  They contain fast-acting myosin ATPases like the type IIB fibres, but 
have an oxidative capacity more akin to that of the type I fibres [55, 56]. 
 
Different myofibre subtypes are also detected during embryonic life [58], and 
patterning of fibre types within major muscle groups is established postnatally 
depending on the functional requirements of the muscle [59].  Most noticeably during 
the first postnatal week, the myosin heavy chain transition is complex and as many 
as five different isoforms are expressed concurrently in a particular muscle [60].  In 
fast-contracting rat muscle, neonatal myosin replaces the embryonic isoform and is 
the predominant fibre type by days 7-11 after birth, followed by the replacement of 
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the neonatal myosin by the adult fast isoforms [61].  Development of slow muscle 
fibres can occur by several pathways, but similarly involves myosin isoform 
transitions [62].  Studies on mouse [63], rat [64], and human [65] show that during 
the foetal stages of development, most fibres express the embryonic and neonatal 
myosin isoform, while a small percentage of fibres express the slow type 1 isoform.  
However, it was concluded in a study by McKoy et al. (1998) that this expression 
pattern of different myosin heavy chain isoforms is not related to muscle-specific 
activity [66].  As the animal matures, individual muscles become adapted to perform 
highly specialised functions by predominantly expressing one or two myosin 
isoforms.  In early postnatal development the speed of contraction of slow muscle 
changes less than the fast.  During the first 20 days of life, both fast and slow 
muscles of rats increase their speed of contraction significantly, and by day 30, each 
muscle fibre has stabilized at the adult value [60].   
 
Staining muscle sections for mATPases histologically, clearly indicates the difference 
in Type I and Type II fibres according to their myofibrillar ATPase activity, since 
ATPases of different fibre types display differential pH sensitivity [30, 56].   
 
 
1.3  Skeletal muscle injury and repair 
1.3.1  Introduction 
Tissues in the body are not isolated:  they combine to form organs with diverse 
functions.  Any injury to the body affects several different tissue types 
simultaneously, and these tissues must respond in a coordinated manner to 
preserve homeostasis [27].  The basal lamina, which surrounds muscle fibres plays 
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an important role during recovery from injury.  In injuries where the basal lamina 
remains intact (e.g. contusion injury), recovery is relatively complete.  Conversely, in 
cases where the basal lamina is destroyed (e.g. injury causing ischemia) [67], fibre 
regeneration first requires the laying down of a new scaffold by newly generated 
fibres with the help of satellite cells, in the early stages of recovery [28].  In both 
cases, recovery will take place, but the latter injury is more severe and recovery 
might take longer.  After an injury, the healing of skeletal muscle can take several 
weeks and although injured muscles can initiate regeneration promptly, the healing 
process is often inefficient and hindered by the formation of scar tissue, which may 
contribute to the tendency for muscle injury to occur again [27].  The response of 
skeletal muscle following an injury will be discussed in more detail in the next 
section. 
 
1.3.2  The muscle’s response to injury 
There are many ways in which muscle fibres can be damaged.  External causes 
include contusion and laceration injuries to the body, or extremities of heat or cold, 
whereas internal causes include muscle tears and tendon ruptures following sudden 
forceful contractions [14].  The response of skeletal muscle to injury follows a fairly 
consistent pattern, irrespective of its cause.  The response of muscle to contusion 
injury will be the focus of this thesis.   
 
Usually, the underlying bone is not broken during a contusion injury, but when an 
injury results in the breaking of bone, the healing tissue (the bone) is identical to the 
tissue that existed there before.  This process is termed regeneration.  However, the 
healing of injured muscle may include the formation of a scar, which is termed repair 
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alongside the generation of new contractile tissue.  Therefore, regeneration is not 
only used to refer to the healing of bone, but also to the healing of muscle after 
injury.  Although these two processes are different from one another, the terms 
regeneration and repair are often used interchangeably by researchers [19].   
  
Although the overall injury response process in skeletal muscle, is most correctly 
termed regeneration, it can be divided into three distinct phases (for review see 
Jarvinen et al. 2005) [19].  The first is actually a destruction phase, which is 
characterised by the disruption of the vasculature and muscle ultrastructure, followed 
by the formation of a haematoma, necrosis of the damaged muscle fibres, and a pro-
inflammatory immune response.  This is followed by the repair phase, which consists 
of numerous overlapping processes, including phagocytosis of the damaged muscle 
tissue, activation of satellite cells, production of a connective-tissue scar and 
capillary revascularisation. During the third and final phase, the remodelling phase, 
formation of new or regenerated muscle fibres reaches completion along with 
reorganisation of the scar tissue.  These three phases are usually closely associated 
or overlapping as graphically illustrated in Figure 1.2, making temporal resolution 
difficult.  
 
For the purpose of this thesis, further discussion of the events following an injury will 
focus on three main topics with particular reference to reactive species production: 
the first part will focus on the early events following a contusion injury (pro-
inflammatory response included), the second part will focus on the resolution of 
inflammation and concomitant resolution of muscle damage, and the last part on the 
necessity of satellite cells in regeneration.    
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Figure 1.2:  Time course of regeneration of injured muscle.  
 
 
1.3.3  Inflammation, leukocyte infiltration and secondary damage: the early 
response 
Following a mild contusion injury, the vasculature in the skeletal muscle is usually 
bruised but not disrupted, although the muscle fibres themselves rupture at or 
adjacent to the impact area [19].  Therefore, the arterioles within the injured area can 
dilate, in response to histamine release from mast cells as well as from activated 
platelets (both residing in the tissues near blood vessels), which in turn will increase 
the blood flow to the site of injury [68].  A second effect of this localised histamine 
release is an increase in capillary permeability at the site of injury, which causes the 
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away from one another [69].  When the cells retract from one another, gaps are 
formed, known as capillary endothelial pores, that permit fluid and plasma molecules 
to flow freely from the bloodstream out into the tissues [69].  As a result, an increase 
in the numbers of phagocytic leukocytes and plasma proteins, both crucial to the 
inflammatory response [68], are seen in and around the damaged tissue [70].  This 
process does not damage the endothelial cells, and after roughly 1 hr, they spread 
back out and re-establish connections with their neighbours [69].    
 
With severe injury, much of the vasculature is also extensively disrupted, exposing 
the collagen in the subendothelial layers of blood vessels, which occurs after the 
muscle fibres and sarcoplasm have ruptured and torn.  Following this, a process of 
“damage control” is initiated immediately.  Platelets adhere to the exposed collagen, 
become activated as a result and start to release pro-inflammatory mediators such 
as 5-hydroxy tryptamine (serotonin), histamine and thromboxane A2 (TxA2).  
Following formation of a platelet plug and the control of haemorrhage, blood-borne 
immune cells begin to migrate into the area of tissue damage [19].  A chronological 
illustration of white blood cell (WBC) involvement in the response to skeletal muscle 
injury is presented in Figure 1.3. 
 
Immediately following the injury, neutrophils are the predominant cell infiltrate.  For 
mild and moderate damage, they enter the injured area by way of rolling (via 
selectins), adhesion (via integrins) and migration through areas of intact capillary 
endothelium and across layers of basement membrane and sarcolemma by means 
of pro-inflammatory mediators (released by the activated platelets), as well as   
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Figure 1.3:  Illustration of chronological involvement of peripheral immune cells 
following a contusion injury. Cell counts are represented relative to the maximum 
response seen.  The duration of increased cell numbers in circulation may vary 
depending on the extent of tissue trauma.   
 
 
complement component C5 [71].  Although the literature does not clearly compare 
possible differences due to injury extent, it is likely that in severely injured muscle, 
neutrophils spill into the injured area from disrupted capillaries and adhere to 
exposed integrins in fragments of disrupted sarcolemma.  Neutrophil infiltration can 
be detected in the damaged muscle within the first hour following injury.  Neutrophil 
cell numbers peak in approximately 24-48 hr and can remain elevated for up to 5 
days [11].  The dominance of neutrophils during the early phase after injury – relative 
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to other immune cells – is partly due to the transfer into the blood of large numbers 
of preformed neutrophils (most abundant WBC in the circulation) from the bone 
marrow, and also an increase in production of new neutrophils in the bone marrow, 
stimulated by the release of chemical mediators from the inflamed region [11, 70], 
including complement components (C5), pro-inflammatory prostaglandins (PGE2 and 
PGF2α) and leukotrienes (LTB4) [72], as well as factors released by activated 
platelets (TxA2, serotonin and histamine) [73].   
 
Neutrophils contribute to the post-injury events in 2 ways:  firstly, the invading 
neutrophils have a phagocytic function [74], clearing the wound of blood-derived 
fibrin [19] and necrotic debris and secondly they initiate the inflammatory process via 
the release of pro-inflammatory cytokines such as IL-6 and TNF- [11, 75, 76].    
 
During the early phase of inflammation, pro-inflammatory cytokines are secreted by 
not only neutrophils, but also activated macrophages which also migrated from blood 
into the damaged tissue [76].  This acute inflammatory response develops rapidly 
and only returns to baseline approximately 10-14 days later when the injured area 
becomes cleared of all damaged tissue [75, 76].  Table 1.2 summarises the different 
cytokines produced by the major cell types present in muscle and their involvement 
in muscle injury and repair processes. These data, and the numerous studies 
published on the topic, illustrate the complexity of the inflammatory process which 
involves several interrelated steps.  Although IL-6 and TNFα are considered most 
frequently, other cytokines such as IL-1, -2 and IL-8 [10, 11] are also involved, as 
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Table 1.2:  Involvement of various cell types in inflammation and muscle injury. 
 
Cell type Cytokines/ Growth factors secreted 
 
Injury-related activity Reference 
Neutrophils IL-1              IL-6             IL-8       TGF-          TNF- 
Source of pro-inflammory cytokines 
First leukocyte to infiltrate injury site 
Phagocytosis of necrotic myofibres and cellular debris 
[76] 
[76]  
[11] 
Monocytes/ 
Macrophages 
FGF-2         IGF-1          IL-1        
IL-6            TGF-         TNF- 
LIF 
Source of growth factors, cytokines & reactive species 
Sending survival factors to regenerative cells 
Promote muscle injury or proliferation in vitro & in vivo 
[11] 
[19] 
[76] 
Fibroblasts IL-1              IL-6            IL-8 
Produce chemotactic signals for circulating inflammatory cells 
Help formation of connective tissue scar 
[19] 
 
 
T lymphocytes 
IL-1              IL-2            IL-6        
TNF-         TGF-        MIF 
IFN-           TNF- 
Involved in immediate hypersensitivity via IL-1 & 6 
Involved in delayed sensitivity reactions via IFN-, TNF- & IL-2 [10] 
B lymphocytes IL-1              IL-2            IL-6         TNF- 
Involved in antibody formation [78] 
 
NK cells IL-1             TNF-         IFN- Causes an increase in lymphocyte concentration [79] 
Eosinophils IL-6 
Capable of generating reactive oxygen species 
[80] 
Platelets TGF- Secretion of adherence factors (P-selectin) to help neutrophils gain access to site of injury [81] [10] 
Injured skeletal muscle 
cells 
IL-1             IL-6            TGF-     
FGF            IGF            HGF 
LIF 
Release growth factors and cytokines which helps to activate 
regeneration [19] [77] 
Keratinocytes IL-1        TNF- 
Act as "signal transducers", which converts exogenous stimuli 
into production of cytokines, adhesion molecules, and 
chemotactic factors  
[82] 
17
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well as related cytokines such as leukaemia inhibitory factor (LIF) [11, 77], migration 
inhibitory factor (MIF) [10] and interferon  (IFN-) [10]. 
 
Neutrophils are generally accepted to play the main role in the early inflammatory 
response to contusion injury, but the involvement of macrophages cannot be 
excluded.  Phagocytosis is a vital process in the recovery from muscle injury, but it 
can damage the injured muscle even further, and may result in secondary damage to 
the healthy surrounding tissue by the generation of reactive species. The processes 
by which this secondary damage occurs are somewhat controversial, and the extent 
to which neutrophils and/or other cell types contribute is not completely understood.  
The role of neutrophils and macrophages in reactive species production will be 
discussed below, but first a brief overview on free radicals and reactive species is 
needed. 
 
1.3.3.1  Free radicals and reactive species  
A free radical is any atom (e.g. oxygen, nitrogen) with at least one unpaired electron 
in the outermost shell, and is capable of independent existence [83].  When a free 
radical reacts with a molecule that is a non-radical, the molecule becomes a new 
radical, and this can result in a radical chain reaction as further reactions with non-
radicals take place [84]. As most biological molecules are non-radicals, the 
generation of reactive radicals in vivo will usually set off a chain of radical reactions.  
Although most of the biologically important free radicals and reactive species are 
derived from or are associated with molecular oxygen, they are not limited to oxygen 
species.  Therefore, for the purposes of this thesis, reactive species will be used as 
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the collective term for all free radicals and other reactive species, including reactive 
oxygen species and reactive nitrogen species.   
 
Reactive species are naturally formed within the body by various physiological 
processes to maintain homeostasis [85].  Reactive species can also be generated 
from exposure to certain chemicals, environmental pollutants, sunlight, radiation, 
burns, cigarette smoke, drugs, alcohol, viruses, bacteria, parasites, dietary fats, and 
more [86-88].  Interestingly, superoxide dismutase, an antioxidant in the body may 
result in free radical generation in a process known as the Fenton reaction [83].  
Superoxide (O2•-) is produced by the addition of a single electron to oxygen 
(Equation 1).  As a result of a spontaneous dismutation reaction, which is catalysed 
by superoxide dismutase, superoxide will form hydrogen peroxide (H2O2) (Equation 
2).  Although hydrogen peroxide is less reactive than other oxygen-derived reactive 
species, it is a biologically important oxidant due to its ability to diffuse considerable 
distances from its site of production but also because it can react with reduced metal 
ions in the Haber-Weiss reaction (referred to as the Fenton reaction) when it is iron 
catalyzed (Equation 3) forming the highly reactive and damaging hydroxyl radical 
(OH•).  In healthy humans, extra cellular fluids have essentially no transition metal 
ions that can catalyse free radical reactions. However, extracellular unbound iron 
may be increased in some cases, such as in iron-overload diseases or where iron 
intake is very high (as can occur through supplementation) and this free iron is then 
available to drive the Fenton reactions.   
O2 + e– → O2•-                  Equation 1 
2O2•- + 2H+ → H2O2 + O2                        Equation 2 
Fe2+ + H2O2 →  OH• + OH- + Fe3+                     Equation 3      
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Thus the incomplete reduction of oxygen may result in the formation of superoxide 
radical, hydrogen peroxide, and hydroxyl radical.  However, within the cell, 
antioxidants can also protect against oxidative damage at different levels including 
preventing radical formation, intercepting formed radicals, repairing damage caused 
by radicals, eliminating damaged molecules and preventing mutations from occurring 
[26].  The role of antioxidants will be discussed in detail later.  
 
Reactive species have been implicated in the pathogenesis of a wide spectrum of 
diseases as well as in the aging process [89].  In addition to these primary sources of 
reactive species, they can also be formed in the haematoma after sustaining an 
injury, exacerbating the muscle necrosis by extending the zone of injury to include 
neighbouring healthy myofibres [19].  These secondary sources of reactive species, 
may amplify the body’s general inflammatory response and promote further cell 
injury [89].  A number of other secondary sources of reactive species within muscle 
are likely to be important after the onset of damage (e.g. contusion injury) initiated by 
other mechanisms.  This secondary generation of reactive species may be important 
in spreading and worsening the damaging processes, or may merely be part of the 
body’s adaptive responses to ensure that efficient preparation of the damaged tissue 
allows regeneration to occur [90].  Other sources of reactive species, apart from the 
reactive species generated by free iron in the Fenton reaction, include:  reactive 
specie generation by phagocytic white blood cells, mainly neutrophils and 
macrophages following injury. 
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1.3.3.2  Reactive species generation by phagocytic white cells and macrophages 
It is clear that substantial injury to muscle fibres is followed by the invasion of the 
area by macrophages and other phagocytic cells from the blood and interstitium [9].  
These infiltrating cells appear to be essential to prepare the tissue to allow for fast, 
effective regeneration to occur.  As part of the phagocytic process, they release 
substantial amounts of reactive species to aid in the degeneration of necrotic areas, 
but can also contribute to damage of surrounding healthy tissue [91].  This increase 
in reactive species generation is independent of the type of tissue injury and will 
occur in all tissue damaged in vivo.  Thus, direct trauma to muscle during exercise or 
by means of contusion can cause damage that will eventually lead to a secondary 
increase in intramuscular reactive species generation from phagocytic cells [90, 92].   
 
An in vivo study by Nguygen and Tidball (2003) shows that neutrophils lyse muscle 
cells through superoxide-dependent mechanisms [93], which is consistent with other 
in vitro findings [94-96].  However, no significant lysis through superoxide-dependent 
mechanisms was detected when macrophages were also present at 
macrophage/neutrophil ratios that usually occur in muscle injury and inflammation.  
Furthermore, the addition of low concentrations of neutrophils (lower than the usual 
concentrations required after muscle injury) to macrophages in muscle co-cultures 
resulted in the activation of more macrophages, thereby promoting the 
overexpression of nitric oxide [93].  Also, the presence of muscle cells increased 
nitric oxide production by macrophages even further, suggesting that there might be 
a feedback mechanism promoting the production of nitric oxide by macrophages 
[93].  However, it should be mentioned that the ratio of neutrophils to macrophages 
Stellenbosch University  http://scholar.sun.ac.za 
 22
used in the study by Nguuyen and Tidball (2003), is not the same as it would be in 
vivo. 
    
Macrophages also increase muscle membrane (sarcolemma) lysis in vivo in the mdx 
mouse model of muscular dystrophy.  In the presence of macrophages, an increased 
susceptibility of the cell membrane to mechanical damage during muscle contraction, 
which leads to muscle inflammation and membrane lysis, were apparent [97].  In 
another study, production of macrophages was inhibited by injecting mdx mice with 
an antibody (anti-F4/80), depleting the muscle of macrophages and therefore 
reducing the amount of nitric oxide produced.  This led to an 80 % reduction in 
sarcolemma lysis in vivo [98].   These findings show that not only do neutrophils play 
a major role in promoting secondary muscle damage, but macrophages also 
contribute in promoting muscle damage through the increased production of reactive 
species (nitric oxide - NO) apparent after injury.  Although not mentioned in the 
vague studies above, it is also possible that other membranes beside the 
sarcolemma could be involved e.g. the mitochondrial membrane and nuclear 
envelope.  However, no evidence has been provided to include these membranes 
mentioned above.  
 
1.3.4  Resolution of skeletal muscle damage:  the late response 
Initiation of injury resolution may be defined as the point in time following the injury 
when the number of neutrophils in the region of damage begins to decrease [19].  A 
concomitant rise in the number of macrophages is seen with this decline in 
neutrophil number.  The recruitment of circulating macrophages to the site of injury is 
secondary to chemotactic factors released by both platelets and neutrophils [9, 19].  
Stellenbosch University  http://scholar.sun.ac.za 
 23
The main function of macrophages is thought to be the removal of damaged muscle 
fibres from the tissue by means of phagocytosis [99, 100].  Approximately nine 
different macrophage subtypes exist [76], but these subtypes will not be discussed 
further, as this is not the main focus of this thesis.  Although the exact contribution of 
the different macrophage subtypes to the healing process is unclear, a number of 
studies reported a beneficial role for these macrophages in regenerating muscle 
fibres, suggesting that these macrophages may be involved not only in the pro-
inflammatory process but maybe also serve as a major source of growth factors and 
cytokines that promote healing [101]. One specific aspect of macrophages’ beneficial 
role has previously been discussed in section 1.3.3.2 where it was reported that 
when the numbers of neutrophils decrease and macrophages increase (as happens 
during the late phase), the production of NO by macrophages is increased, with no 
significant muscle cell lysis occurring [93].   
 
Not only do macrophages and neutrophils play an important role in the healing of 
injured skeletal muscle, but satellite cells also contribute significantly to skeletal 
muscle regeneration.  Indeed these satellite cells may be the mechanism mediating 
the positive effects of the growth factors.  The different cells supplying growth factors 
can be seen in Table 1.2 and their effect on satellite cells will be explained in the 
next section. 
 
1.3.5  Involvement of satellite cells during skeletal muscle regeneration 
Adult mammalian skeletal muscle is a stable tissue with little turnover of nuclei; only 
approximately 1-2 % of myonuclei (nuclei of muscle fibres) are replaced each week 
[102].  Nonetheless, mammalian skeletal muscle has the ability to regenerate injured 
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myofibres after extensive muscular damage through the involvement of satellite 
cells.   
 
As mentioned earlier, satellite cells are a population of mononucleated progenitor 
cells specific to skeletal muscle and reside under the basal lamina and one of the 
layers of the sarcolemma in mature and growing muscle (see figure 1.1 for detail).  In 
contrast to myonuclei, satellite cells are quiescent under normal circumstances.  In 
response to muscular trauma, enhanced recruitment and activation of satellite cells 
is evident [12-14].  Upon muscle injury, reactive species (refer to section 1.3.3) are 
formed when satellite cells exit their normal quiescent state, become activated and 
start proliferating to form adult myoblasts, also known as myogenic precursor cells 
(MPCs) [16].  The resulting myoblasts, after several rounds of proliferation, 
differentiate and can either fuse with other myoblasts to form new myofibres or with 
damaged fibres in order to repair them [15].  It should be noted that satellite cell 
activation is not restricted to the damaged area – many satellite cells within a fibre 
get activated, even when only one end of the myofibre is injured, compared to when 
the whole fibre is damaged [103, 104].  However, recruitment of satellite cells from 
adjacent muscle fibres is very rare and thought to only take place if the connective 
tissue between the muscle fibres is also damaged [103, 104].  Following satellite cell 
activation, the proliferation and differentiation cycle is characterised by expression of 
the myogenic regulatory factors (MRFs).  These MRFs consist of MyoD, Myf5, 
myogenin and MRF4.  MyoD and Myf5 are also expressed during muscle 
development, and are involved in the determination of the myogenic lineage.  They 
are also expressed early during satellite cell activation and proliferation.  Myogenin 
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and MRF4 are expressed later as myoblasts progress through differentiation and are 
thought to act specifically as differentiation factors [105].   
 
Skeletal muscle regeneration is a highly orchestrated process, which is regulated 
through mechanisms involving cell-cell and cell-matrix interactions as well as 
extracellularly secreted factors [24].  Mechanisms that are controlled or altered by 
growth factors (Table 1.2) include satellite cell activation, migration to the injury site, 
proliferation of satellite cell-derived progeny MPCs and the differentiation of these 
MPCs into myotubes and myofibres.  In vitro studies making use of monolayer cell 
lines in culture have identified several factors responsible for the activation of 
satellite cells [106-108].  These include fibroblast growth factor (FGF) [106-108], 
hepatocyte growth factor (HGF) [109], insulin-like growth factor (IGF) [110, 111], 
leukaemia inhibitory factor (LIF) [112, 113], vascular endothelial growth factor 
(VEGF) [114] and interleukins, including IL-6 and IL-1 [112, 113], and nitric oxide 
(NO) [115].  All these role players are involved in maintaining a balance between 
proliferation (growth) and differentiation of satellite cells to restore normal muscle 
architecture.  The next section will focus on the interaction between NO and satellite 
cells.  
 
1.3.5.1  Satellite cells regulate reactive species production 
Muscle-derived nitric oxide appears to be a particularly important regulator of muscle 
inflammation and muscle damage by invading inflammatory cells.  Due to the fact 
that satellite cells are positioned so close to fibres and often stay attached to the 
external lamina as the sarcolemma buckles after injury [116], they are ideally 
positioned to be the “first responders” to an injury-induced release of nitric oxide from 
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nitric oxide synthase (NOS).  Anderson (2000) demonstrated that satellite cell 
activation that occurs immediately upon muscle injury, is mediated by nitric oxide 
released from circulating macrophages and is ultimately required for muscle 
hypertrophy [117].  However, some evidence suggests that the effect of nitric oxide 
is concentration and time dependent, evident only at the onset of differentiation, and 
directed on the fusion process itself [118].  Also, recent investigations have provided 
new insights into specific mechanisms through which both satellite cells and muscle 
fibres can regulate reactive species production by inflammatory cells, contributing to 
either muscle injury or growth.  Satellite cells themselves, after activation and prior to 
proliferation, also release factors which attract more macrophages and monocytes to 
the injured area, these cells being responsible for the production of more nitric oxide 
[119].  The build-up of huge quantities of nitric oxide could result in nitric oxide-
dependent cytotoxicity, as described earlier.  
 
1.3.5.2  Satellite cell identification 
According to the literature, adult muscle satellite cell nuclei represent about 3-6 % of 
all muscle nuclei.  From animal experiments, it has been reported that their 
percentage differs in different types of muscles and muscle fibre types and may also 
differ between animal species [120].  Satellite cells are therefore associated with all 
muscle fibre types, albeit with unequal distribution.  Higher numbers of satellite cells 
are found adjacent to slow-twitch muscle fibres in comparison to fast-twitch muscle 
fibres [120].  Increased density of satellite cells have also been identified at the 
motor neuron junctions and adjacent to capillaries, suggesting that some factors 
originating from these structures may play a role in either homing satellite cells to 
specific locations or in regulating the satellite cell pool by other means [24].  
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Therefore, although satellite cells are so widely distributed, the most reliable way to 
identify satellite cells is on the basis of their position, situated between the 
sarcolemma and basal lamina of skeletal muscle, using fluorescence or electron 
microscopy.  Although different markers have been introduced for satellite cell 
identification, such as M-cadherin (M-cad) [121], NCAM (CD56) [122], CD34 [123], 
Pax7 [124], c-met [15], myoD [125] and myogenin [126], direct comparison of 
identification by these different markers has not been done.  Therefore it is difficult to 
judge which marker stains all satellite cells.  The satellite cell markers used for the 
purpose of this study will be discussed below. 
 
M-cadherin 
One of the most widely used markers for satellite cells appears to be the cell surface 
protein M-cadherin (M-cad) which is located at the interface of the satellite cell and 
the underlying myofibre [12, 13].  M-cad, a particular member of the cadherin family, 
has been identified in skeletal muscle cell lines in situ, in prenatal and postnatal 
skeletal muscle, and in developing and regenerating muscle [121, 127-129].  The 
cadherins are members of a multigene family of transmembrane calcium-dependent 
intercellular adhesion molecules which influence morphological processes such as 
tissue development and maintenance, and in particular the establishment of 
intercellular junctions [128, 130].     
 
Functional assays performed in cell culture have implied a role for M-cad during 
fusion of mononucleated myoblasts into multinucleated myotubes [130], a process 
which involves extensive changes in components of the cytoskeletal network.  In line 
with this are observations showing that M-cad expression was upregulated during 
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myotube formation during development and although expression declined after 
completion of this process, it was still present in quiescent satellite cells [123, 131-
133].  But not only is M-cad expressed in quiescent satellite cells and just prior to 
fusion, M-cad+ labeling is also seen in activated satellite cells, and according to 
Cooper et al. (1999) it is a reliable marker staining all satellite cells [125].  It has also 
been shown that in activated satellite cells in regenerating muscle (in adult Sprague-
Dawley rats and BALB C and CBA inbred mice), M-cad expression is markedly 
induced, suggesting a functional role in the repair process rather than simply a 
marker carried over from development [121, 133].    However, although it has been 
postulated that M-cad may be essential for the fusion of myobasts into 
multinucleated myofibres [130, 134], Hollnagel et al. (2002), using M-cad-knockout 
mice, found that M-cad is not required for normal skeletal muscle development [135].  
Interestingly, the satellite cells in these mutant mice proliferated and formed 
myotubes in culture and also contained increased amounts of N-cad, suggesting that 
this molecule may substitute for the lack of M-cad.     
 
It has been proposed that satellite cells contain a subpopulation of cells with stem-
like characteristics that serve to replenish the satellite cell compartment, and this is 
the subject of a review by Zammit and Beauchamp (2001), although there is no 
evidence to confirm this [18].  Kuschel et al. (1999), used a satellite cell culture 
model within normal and denervated muscle [136], in order to characterise the 
proliferative and differentiative potential of satellite cells.  In this study it was 
demonstrated that in normal muscle, a second satellite cell phenotype exists in 
addition to the proliferating-differentiating compartment, which is M-cad+/myogenin- 
and which is therefore non-differentiating.  The reliability of M-cad as a molecular 
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marker of satellite cells has however also been questioned [15].  Cornelison et al. 
(1997) found that M-cad mRNA was only present in a small subset of satellite cells at 
early times after myofibre explant, and not in all quiescent satellite cells.  After 
activation however, M-cad was expressed by all activated satellite cells.  Therefore 
care should be taken when interpreting results using M-cad as a molecular marker 
staining all satellite cells. 
 
Subsequently, Wernig et al. (2004) also investigated the proportion of M-cad+ 
satellite cells present in normal mouse muscle.  Of importance is that these 
researchers observed that approximately 94-100 % of all quiescent satellite cells are 
M-cad+ [137], indicating that M-cad is a reliable marker of quiescent satellite cells.  
However, they also concluded that although M-cad is present in most quiescent 
precursor cells, the small fraction of the satellite cell pool which is M-cad- cannot be 
excluded, as was previously claimed by Beauchamp et al. (2000).   
 
CD34 
Structurally, CD34 is a highly O-glycosylated, transmembrane sialomucin, expressed 
by haematopoietic stem cells (HSC) and progenitors [138] and by small-vessel 
endothelium [139].  The expression of CD34 on quiescent adult skeletal muscle 
satellite cells extends the role of CD34 as a marker in the field of progenitor cell 
biology.  CD34 expression has also been associated with activation and progress 
towards self-renewal or differentiation [140].  Recently the status of CD34 as a 
marker of quiescence has come into question, because of the identification of no or 
very low levels of CD34 in HSCs [141].  In quiescence, CD34 is expressed in a 
truncated form, but following activation there is expression of the full length CD34 
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isoform.  Taken together, it seems therefore likely that these two isoforms of CD34 
could have distinct roles in the maintenance and activation of quiescent lineage-
primed progenitors during adult tissue renewal and regeneration.  Co-expression of 
CD34 with M-cad is restricted to the myogenic lineage, suggesting that in adult 
skeletal muscle, CD34 does not mark stem cells but is expressed by precursors that 
are committed to a specific fate and have become arrested and held in reserve for 
subsequent activation [123].   
 
However, although most myogenic cells are CD34+, it is considered not to be a 
useful marker for satellite cells on tissue sections, because CD34 is also present on 
many cells of the vasculature and on HSC [18].  Nevertheless, CD34 is still widely 
used as a marker for quiescent satellite cells, but making use of morphological 
features at the same time which may be considered subjective.  Therefore care 
should be taken when interpreting results using CD34. 
 
CD56/NCAM 
The CD56 antibody recognizes the neural cell adhesion molecule (NCAM), 
expressed during developmental myogenesis and in adult muscle satellite cells 
[142].  It also stains nerves, neuromuscular junctions and the cytoplasm of an 
occasional myofibre [122, 143].  According to various researchers, satellite cells are 
closely attached to the plasma membrane of the adjacent muscle fibre and express 
the adhesion molecules NCAM and M-cad in the quiescent state [116, 121, 129].  
CD56 is also considered to be one of the most useful markers for satellite cells as it 
binds to both quiescent and activated satellite cells without binding to myonuclei 
[144]. 
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Due to the dynamic nature of the satellite cells, various immunohistochemical 
markers, as mentioned above for CD34, require additional information on the specific 
location of the marked cell.  M-cad is also one such marker, which by some 
scientists is believed to be reliable, at least in murine muscle (no mention of reliability 
in rodent muscle).   
 
Summary 
Although our knowledge on the roles of various immune and satellite cells after injury 
is growing, several confounding factors contribute to our lack of understanding of the 
exact roles of these cells in damaged tissue after a contusion injury or injury of any 
kind.  These include inter-individual variations in the severity of injuries that occur in 
humans, as well as the invasive nature of the methods of inflicting injury in some 
models.  In the next section, animal models of muscle injury (invasive and non-
invasive) will be described, with particular emphasis on the variability between the 
different models and the suitability of each for inflammation-related research.   
 
 
1.4  Contusion injury models 
1.4.1  Introduction 
Skeletal muscle contusion injury is a proven method of inducing mechanical injury in 
skeletal muscle [145-147].  However, despite being reliable and standardised, 
several factors could lead to variation in injury severity from researcher to 
researcher.  Technical considerations relevant to this model, which may influence 
the physiological results obtained, are discussed in the next few paragraphs.   
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1.4.2  Invasiveness of injury model 
The model most commonly described in the literature makes use of a single impact 
trauma to the muscle, either with or without prior surgical exposure of a selected 
muscle group [145-150].  For example, the mass-drop injury model originally 
described by Stratton et al. (1984) [151] involves dropping a solid weight with a flat 
impact surface (varying in diameter and mass) from various heights onto the specific 
muscle (See Figure 1.4 for a representative illustration).     
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4:  Representative illustration of a non-invasive, standardised ‘mass-drop 
injury jig’. 
 
 
 
drop 
mass 
   hind limb 
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Both localised and systemic inflammation have been studied using the invasive 
version of this model [145].  Although changes in skeletal muscle expression of 
different pro-inflammatory cytokines (IL-1β, IL-6 and TNF-) were reported, the lack 
of sham operated groups resulted in failure to account for cytokines released as a 
result of the surgical procedure itself [145, 148].  Therefore, ideally, one should 
choose a non-invasive model of injury, as this type of model excludes the possibility 
of infections, as well as immune system activation (which could change the local and 
systemic oxygen radical absorbance capacity) as a result of tissue damage (e.g. 
muscle, skin etc.) due to the surgical procedure itself. 
 
A variation of this model is to place a heavier weight on the muscle, but with no 
impact force (i.e. no impact damage) and leave it in place for a given period of time, 
usually two or more hours [152, 153].  Apart from this model resulting in more severe 
damage due to longer-term occlusion of blood flow, it more closely simulates muscle 
injury incurred in accidents where the subject is trapped, and is therefore not ideally 
suited for studying sports-related injuries [154]. 
 
Forceps crush injury is another invasive model of contusion injury.  Prior to the injury, 
the muscle is surgically exposed (as with invasive mass-drop), placed between the 
jaws of forceps and then bruising is achieved by pinching the forceps manually or by 
dropping a weight onto the forceps.  Apart from the invasiveness of this method, 
manual contusion injury is difficult to deliver reproducibly.  Despite these 
complications, this model has been used, with success, to study skeletal muscle 
regeneration following a contusion injury [149, 150, 155].   
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1.4.3  Characteristics of drop-mass weight 
Both murine and rat models have been used to study contusion injury.  Given the 
difference in body size between mice and rats, it is not unexpected that the mass of 
drop-weights and hence the impact force used to induce injury also differed.  The 
specific protocols previously used in rats to induce contusion injury with the mass-
drop technique were either relatively heavy weights from a relatively small height 
(640 and 700 g from 27 and 25 cm respectively) [151, 156-158], or a smaller weight 
released from a greater height (171 g from 102 cm) [1, 159-161].  Injuries to mice 
have also typically been induced using one of these strategies [145, 148, 162].   
 
The impact surface influences the impact area size and severity of the skeletal 
muscle injury.  When a weight with a flat impact surface is used, an injury of uniform 
severity is achieved, but if a weight with a spherical impact surface is used, the injury 
induced is more severe in the middle of the impact area compared to the periphery.  
The infiltration of immune cells into the site of injury was reported to be more 
concentrated to the middle of the injury when a spherical impactor tip was used than 
with a flat surface [6, 159, 162].  The diameter of the impact surface of weights 
previously reported in the literature also varies, which will also influence the impact 
area.  If a mass with a larger impact surface hits the muscle belly, the injured area 
would be wider than a mass with a smaller impact surface.  Therefore both 
characteristics, the shape and diameter of the impact surface, will influence the 
pattern of infiltration of the immune cells, and thus also impact on secondary 
damage.   
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1.4.4  Selection of muscle group 
Due to the different metabolic phenotypes seen in different muscle fibre types, the 
degree of vascularisation differs between fibre types.  Type I fibres have a high 
demand for oxygen and show a high degree of vascularisation, which provides a rich 
source of oxygen and nutrients to the fibres.  In contrast, type IIB fibres are oxygen 
independent, with a reduced capillary supply when compared to the type I fibres 
[163].  Although whole muscles most frequently contain a mixture of these two and 
an intermediate fibre type, the proportions in which they are found differ substantially 
between different muscles and can also differ between different species or 
individuals within a specific species [164].  To date, the majority of research on 
skeletal muscle crush injury has made use of the gastrocnemius muscle [1, 6, 156-
158, 160-162, 165, 166], or the tibialis anterior muscle [148, 150, 153, 155].  Both of 
these muscles possess type II fibres, but only the gastrocnemius muscle is a mixed 
muscle, also containing type I fibres [167].  In addition, the gastrocnemius muscle is 
relatively large, which makes it possible to injure the muscle without bone 
involvement.  The belly-shaped/fusiform nature of gastrocnemius muscle is similar to 
that of the biceps muscle, which frequently suffers contusion injuries in many contact 
sports, particularly the game of rugby.   Therefore, in our opinion, the gastrocnemius 
muscle is the better candidate to use when studying sports-related injuries. 
 
With regard to the immune and cytokine system, it has been shown that muscle 
fibres secrete cytokines in a fibre-type specific manner.  For example, in the triceps, 
vastus and soleus muscles of humans at rest, TNF- and IL-18 were expressed in 
type II fibres only, while IL-6 expression was more prominent in type I than in type II 
[168].  
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1.4.5  Contractile status of the muscle  
The contractile status of the muscle at the time of injury has been shown to influence 
the muscle’s susceptibility to injury [159].  In this study, muscle was shown to be less 
susceptible to injury when in the maximally contracted state.  However, the extent of 
muscle relaxation was also a factor.  Muscles were only fully relaxed after general 
anaesthesia – highlighting the importance of similar protocols for animal treatment 
during such experiments.   
 
In sports, contusion injuries occur both during practices and in competition. Thus, all 
contusion injuries will be accompanied by recent prior exercise and, if not severe, 
also by subsequent exercise.  Treatments to augment the normal repair and 
regenerative processes are important to a wide variety of patients ranging from elite 
athletes to the elderly, who want to return to their previous levels of function as 
quickly as possible. 
 
 
1.5  Current and experimental therapeutics of skeletal muscle injuries 
1.5.1  Introduction 
Blunt-force muscle trauma is frequently seen in contact sports in which opposing 
players cause a muscle contusion by direct impact on the muscle belly.  This can 
produce significant disability because of pain and impaired muscle function often 
resulting in a loss of flexibility, and strength, placing the player at an increased risk of 
re-injury [169].  Traditionally, treatments have focused on conservative techniques 
such as rest, ice, compression, and elevation (RICE), heat, or immobilisation.  Other 
treatment options include continuous passive motion machines and anti-
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inflammatory or other drugs [2].  Some of the different treatments mentioned above 
will be discussed in detail below. 
 
1.5.2  Cryotherapy 
The application of ice (cryotherapy) facilitates recovery from contusion injuries as 
determined by decreased nerve conduction, reduced muscle spasms, and limited 
oedema [170], resulting in a decrease in the severity of local cellular damage by 
restricting the haemorrhage and reducing the metabolic demands of the injured 
tissue after injury [171].  However, the exact mechanism associated with the 
therapeutic efficacy of this treatment is still unclear.  In contrast to the use of 
cryotherapy, some researchers believe that application of heat to the site of injury, 
accompanied by careful passive and active stretching, has a better effect on healing 
[172-174].  According to their reports, warm muscles have improved elasticity and 
could stretch further before failure, therefore reducing the chance of re-injury when 
stimulated.  But, nonetheless, warm muscles were more deformed and absorbed 
less energy than cold muscles.  Furthermore, all the measurements used in the 
studies above were objective and focussed on the functional aspects of the 
damaged muscle, irrespective of the extent of damage and healing of the injured 
muscle.  
 
1.5.3  Nonsteroidal anti-inflammatory drugs 
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is frequently supported 
because animal studies have shown a marked inflammatory response to an 
experimental contusion injury [175].  However, some controversy about the safety 
and efficacy of NSAID treatment in the acute and subacute phase after injury does 
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exist.  On the one hand, NSAIDs may decrease the inflammatory response and 
thereby the pain and swelling [176, 177], but on the other hand, NSAIDs treatment 
has been reported to delay muscle regeneration [178].  Since the inflammatory 
response is a necessary phase during soft tissue healing, inhibition of this response 
could result in poor healing [6].  Another potential concern is that NSAIDs have no 
direct effect on satellite cell activation and proliferation [166], processes which are 
required for the regenerative response after loss of muscle fibres.  Although certain 
concerns exist regarding the safety of these drugs, a recent review concluded that 
NSAIDs have a role in the short-term treatment of delayed onset muscle soreness 
(DOMS) in humans [179].  NSAIDs have also been shown not to affect long-term 
muscle repair, if administered at low doses after contusion injury, since the 
inflammatory response (important in muscle regeneration) is most probably not 
completely suppressed at low doses [150].   
 
1.5.4  Steroids 
Corticosteroids, despite promoting catabolism of muscle and inhibiting the healing 
process, have been used to treat muscle contusion injuries and are usually injected 
directly into the site of injury.  However, corticosteroids were only shown to alleviate 
pain and thereby to expedite a player’s return to active status.  With no added 
beneficial effect on the regenerative capacity of the muscle, this may therefore not 
be at all beneficial to the athlete [180-183].  Anabolic steroids have also been 
contrasted with corticosteroids with regard to their effects on muscle tissue, with 
widely conflicting reports on their advantages and disadvantages.  Although not 
considered to have anti-inflammatory properties, anabolic steroids have been shown 
to promote muscle growth and regeneration in some circumstances [184-186] and 
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are now being considered as a possible treatment option following severe contusion 
injuries [6].  Beiner et al. (1999) found that nandrolone decanoate, a testosterone 
derivative, was able to increase the number of muscle progenitor cells in injured 
muscle, rapidly healing and restoring force generation capacity.  The effect was also 
associated with an increase in inflammatory cells.  This therefore suggests that the 
initial inflammatory process is a crucial part of the entire healing response [6].   
 
1.5.5  Therapeutic ultrasound 
Therapeutic ultrasound is one of the most frequently used treatment modalities for a 
variety of both athletic and nonathletic injuries, and although it has been used for 
decades as treatment, there is no good evidence which suggests its effectiveness for 
treating pain, muscoskeletal injuries or soft tissue injuries [187, 188].  Despite this, 
ultrasound has been extensively used for treatment of sports-related contusion 
injuries to skeletal muscle.  According to Wilkin et al. (2004), for ultrasound to be an 
effective treatment, it should speed up the regenerative process, primarily by 
increasing cell permeability, thereby permitting an earlier entry of macrophage and 
other WBC into the damaged area, which will further speed up the inflammatory 
process.  This should then stimulate the release of growth factors that will initiate the 
regenerative process [161].  The results of their experiments, however, suggested 
that following contusion injury, pulsed therapeutic ultrasound treatment had no 
influence on measured markers of skeletal muscle regeneration – changes in muscle 
mass, protein concentration, cross-sectional area (CSA), and myonuclear number, 
thereby suggesting that ultrasound is actually not that effective.  However, the 
markers of regeneration mentioned above, are not considered to be the best 
markers for regeneration.  Further research is therefore needed to include more 
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markers of regeneration, mainly focussing on satellite cells and immune cells known 
to be involved in the healing of skeletal muscle following injury.     
 
1.5.6  Gene therapy 
Gene therapy is another technique that could be used to deliver growth factors to 
injured skeletal muscle.  The common means of delivery are direct injection, 
transmission via a viral vector, and transmission via a nonviral vector.  One potential 
advantage associated with using human recombinant growth factors in the treatment 
of muscle injuries is the ease and safety of the injection procedure into rodent 
models.  However, the direct injection of recombinant proteins (growth factors) is 
limited by the high concentration of the factor typically required to produce a 
substantial effect.  The vascular system’s rapid clearance of the molecules and the 
molecules’ relatively short biological half-lives are the main reasons that large 
concentrations of growth factor are required [189, 190].  Both viral vectors 
(adenovirus, retrovirus, herpes simplex virus, and adeno-associated virus) and 
nonviral vectors (plasmid DNA and liposomes) have been used to deliver genes to 
injured skeletal muscle.  Each of these vector systems has advantages and 
disadvantages, but the ability of the adenovirus to efficiently transduce regenerating 
myofibres has prompted researchers to focus on adenoviral vectors as promising 
gene delivery vehicles [191, 192].  
 
1.5.7  Nutritional supplements 
Nutritional supplements have become increasingly popular in the treatment of many 
conditions.  Of particular interest is the belief that pre-supplementation before 
exercise may induce a preventive effect if an injury is sustained during exercise, by 
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targeting reactive species production (particularly ROS), which is excessively 
produced after sustaining an injury.  The following section will focus on antioxidants 
as a possible treatment regime for contusion injuries.   
 
1.5.8  Antioxidants 
Antioxidants are important protectors of health because they provide electrons that 
neutralize reactive species [26].  Antioxidants are naturally occurring substances 
which function to protect against the harmful effects of pro-oxidants by inhibiting their 
oxidation.  Antioxidant compounds must however be present in biological systems in 
sufficient concentrations to prevent accumulation of pro-oxidant molecules, a state 
known as oxidative stress [193].   
 
In general, the mammalian cell has adequate antioxidant reserves to cope with ROS 
production under normal physiological conditions as well as following an insult.  A 
variety of proteins and enzymes in the body function as antioxidants.  Such 
substances include catalase (Cat), reduced glutathione (GSH), selenium-dependent 
glutathione peroxidase (GPX), copper and zinc-dependent superoxide dismutase 
(SOD), uric acid and the transition metal-binding proteins, such as transferrin and 
ceruloplasmin [193, 194].  The levels of these protein-derived antioxidants are 
determined by their rate of synthesis, and therefore cannot be manipulated easily.  In 
addition to these endogenous antioxidants, one can obtain oxygen scavengers from 
dietary sources.  The common dietary antioxidants are tocopherols (vitamin E), 
ascorbic acid (vitamin C), carotenoids, selenium and flavonoids [193, 194].  Since 
these dietary antioxidants are exogenous in nature, their levels can be manipulated 
by supplements and dietary modifications [193].   
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Skeletal muscles are rarely thought of as a primary target of oxidative stress.    In 
fact, they can withstand various stressors.  However, during a sustained bout of 
exercise for example, there is increased mitochondrial respiration, allowing for 
greater radical species production.  In addition to these findings, in response to 
exercise-related muscle damage, neutrophils and macrophages migrate to the site of 
injury, infiltrate injured muscle tissue, express and release certain cytokines (Table 
1.2), and produce additional reactive species [195, 196].  Excess generation of 
reactive species may overwhelm natural cellular antioxidant defences such as 
muscle membrane vitamin E, and further contribute to muscle damage [197, 198]. 
 
Some authors have claimed that antioxidants including vitamin C, vitamin E, 
carotenoids and flavonoids can act as pro-oxidants and can stimulate oxidative 
damage in vivo and in vitro, especially ascorbate, alleged in several studies to 
increase oxidative DNA damage (reviewed in Duarte and Lunec (2005)) [199].  
These antioxidants are able to reduce transition metals to generate transition metal 
ions that can stimulate reactive species generation.  However, overall, the data 
suggesting that antioxidants may be harmful by acting as pro-oxidants are unclear 
and inconclusive.  In the next section attention will be focused on an antioxidant 
potentially more powerful than some of the most widely known antioxidants. 
 
1.5.7.1  Oxiprovin™ 
Oxiprovin™ grape seed extract (GSE) is an antioxidant manufactured from grape 
seeds in a water and ethanol extraction process [200].  Oxiprovin™ is one of several 
GSE products available, eg. Procydin, but is the only GSE supplement made from 
South African raw products, whereas all other products used imported components.  
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GSE contains an active component of oligomeric proanthocyanidins (OPCs - 
approximately 100 %).  These proanthocyanidins are a class of polyphenolic 
compounds found throughout nature in plant species and may be present as 
individual monomers or, in some cases as oligomeric units, as is the case with 
Oxiprovin™ [201, 202].  Typically, OPCs are found in the outer shells of seeds and 
barks, where they protect the plants against reactive species (free radical) damage.  
They are one of the most potent antioxidants found in nature [201-203].  These 
OPCs are part of the flavonoid family - natural plant components that strengthen and 
protect living tissue [201-203].  This flavonoid family includes anthocyanidins, 
monomeric flavanols - epicatechin and catechin - which when bound together form 
oligomeric proanthocyanidins, flavanones, flavones and flavonols (see Table 1.3 for 
dietary sources of flavonoids) [204].   
 
Table 1.3:  Dietary sources of flavonoids 
 
Flavonoids Dietary sources 
 
References 
Flavanone 
      
Peel of citrus fruits, citrus fruits [222-224] 
Flavonol Endive, leek, broccoli, radish, grapefruit, black 
tea, onion, lettuce, cranberry, apple skin, berries, 
olive, red wine, grapes 
 
[215, 216, 224-
226] 
Flavone 
 
Fruit skin, celery, parsley [215, 224, 226] 
Anthocyanidins Red grapes, red wine, cherry, raspberry, 
strawberry, coloured fruit and peels 
 
[213, 227] 
Flavanols 
 Monomeric flavanols 
   Catechin 
   Epicatechin 
Proanthocyanidins 
Wheat, corn, rice, tomatoes, spinach, cabbage, 
asparagus, white grapes, white wine, olives, olive 
oil, coffee, apples, pears, cherries, plums, 
peaches, apricots, blackberries, blueberries, 
cranberries, anis, green and black teas, red wine, 
chocolate, beans, grape seeds and skins  
 
[213, 228, 229] 
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Diets rich in fruit and vegetables, thus high in the antioxidants vitamin C, β-carotene, 
carotenoids and plant phenolics including flavonoids, have been shown to be 
beneficial in various situations [205].  The biological, medicinal and pharmacological 
properties of the flavonoids have been extensively reviewed [21].  Flavonoids and 
other plant phenolics are reported, in addition to their free radical scavenging activity 
[206-210], to have multiple biological activities including vasodilatory [211-213], 
anticarcinogenic [214-216], anti-inflammatory [217], antibacterial [218], immune-
stimulating [219], anti-allergic [217], and antiviral effects [218].  Flavonoids have also 
been reported to exert inhibitory effects on phospholipase A2, cyclooxygenase, and 
lipoxygenase, glutathione reductase, and xanthine oxidase [21, 206, 214, 220, 221]. 
 
In contrast to the beneficial effects, some flavonoids have also been found in vitro to 
be mutagenic [230, 231].  These harmful effects were suspected to result from the 
pro-oxidant rather than antioxidant action of these flavonoids.  The biological and 
pharmacological effects of a flavonoid compound may depend upon its behavior as 
either an antioxidant or a pro-oxidant.  Using the ORAC assay, it was demonstrated 
that the same flavonoids could behave as both antioxidants and pro-oxidants, 
depending on concentration and free radical source [221].  Flavonoids acted as 
antioxidants against free radicals but demonstrated pro-oxidant activity when a 
transition metal was available.  The antioxidant activities and the copper-initiated 
pro-oxidant activities of these flavonoids depended on the number of free OH 
substitutions on its structure, the more OH substitutions, the stronger the pro-oxidant 
activity [21].  But, although it seems that flavonoids, as well as other antioxidants can 
behave as pro-oxidants, the copper-initiated pro-oxidant actions of flavonoids and 
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other antioxidants including ascorbic acid and α-tocopherol may not be important in 
vivo, where copper ion will be largely sequestered, except perhaps in certain metal 
overload diseases.  However, the pro-oxidant effect of flavonoids in vivo is still 
unclear. 
 
The free radical scavenging abilities of flavonoids have been well documented and 
command the most attention relative to other antioxidants [206, 207].  However, 
research on the bioavailability of flavonoids suggests that they are poorly absorbed 
[232].  Studies regarding proanthocyanidins and their bioavailability have also only 
recently been investigated (reviewed in Rasmussen et al. (2005)) [233].  According 
to these studies, only the monomeric and dimeric proanthocyanidins are able to be 
absorbed in their intact form and only to a very limited extent, whereas the polymers 
are non-bioavailable and transfer unaltered through the gastro-intestinal system.  A 
few studies indicate that some procyanidin dimers are able to be absorbed intact in 
rats and humans, whereas others have not been able to detect any intact dimers.  
Nevertheless, in vivo studies on mice have shown grape seed proanthocyanidin  
extract (100 mg/kg) to be a better free radical scavenger and inhibitor of oxidative 
tissue damage than vitamin C (100 mg/kg), E succinate (100 mg/kg), and β-carotene 
(50 mg/kg) [206].  Oxidative tissue damage in this study was assessed by the 
following assays:  the chemiluminescence assay as an index of ROS production, the 
cytochrome C assay as an index of superoxide anion production, and the 
thiobarbituric acid reactive substances (TBARS) assay as an index of lipid 
peroxidation.  Recently, grape seed proanthocyanidins (GSPE) were also found to 
possess cardioprotective abilities by functioning as an in vivo antioxidant in rats and 
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by virtue of their ability to directly scavenge reactive oxygen species including 
hydroxyl and peroxyl radicals [213].    
     
 For a proanthocyanidin to be defined as an antioxidant it must satisfy two basic 
conditions:  (1)  when present in low concentrations relative to the substrate to be 
oxidized it should be able to delay, retard, or prevent auto-oxidation or free radical-
mediated oxidative injury; and (2) the resulting product formed after scavenging must 
be stable (through intramolecular hydrogen bonding) on further oxidation [234].  
Proanthocyanidins have also attracted increased attention in the fields of nutrition, 
health, and medicine largely due to their potent antioxidant capacity and possible 
beneficial implications on human health.  But how does one measure the antioxidant 
capacity of a particular sample?     
 
1.5.7.2  Measuring of antioxidant capacity 
Several methods have been developed to assess the total antioxidant capacity of 
human serum or plasma because of the difficulty in measuring each antioxidant 
component separately and the interactions among different antioxidant components 
present in the serum or plasma [235].   
 
The oxygen radical absorption capacity (ORAC) assay is a method for measuring the 
total antioxidant activity of a biological sample, including serum, agricultural 
products, food products, food ingredients, pharmaceutical products and animal 
tissues [236].  The assay measures the effectiveness of various natural antioxidants 
present in the tested sample, in preventing the loss in the fluorescence intensity of 
the fluorescent marker protein, fluorescein, during peroxy radical induced free radical 
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damage [237].  Assay results are quantitated by allowing the reaction to read until 
the fluorescence decay plateaus (e.g. for 35 minutes, i.e. 37 reads, approximately 1 
read per minute) and then integrating the area under the kinetic curve relative to a 
blank reaction containing no added antioxidants.  This method is based on the 
method of Huang et al. (2002), where the area under the curve is proportional to the 
concentration of all the antioxidants present in the sample.  Each reaction is 
calibrated using known standards of 6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid (Trolox), a water soluble vitamin E analog.  The results of the assay 
are reported on the basis of 1 ORAC unit = 1 micro-M Trolox [238]. 
 
The ORAC assay provides a way of evaluating the potential antioxidant activity of 
various compounds and biological samples.  This method, although only water-
soluble antioxidants are assessed, is superior to other methods in determining the 
antioxidant properties of a sample.  Firstly, the ORAC assay is very economical, the 
reagents needed to perform the ORAC assay are relatively cheap and only a small 
volume of the reagents and a small volume of samples are needed.  Secondly, the 
ORAC assay is quick and simple to use, as well as reliable (personal 
communication: Dr. Theo Nell, Department of Physiological Sciences, Stellenbosch 
University).  However, although other more reliable methods exist for measuring the 
antioxidant status of a particular component in the sample, i.e. high performance 
liquid chromatography (HPLC), these methods are more difficult to use, much more 
expensive and time consuming. 
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1.6  Summary  
When damage to skeletal muscle occurs (e.g. contusion injury sustained after 
sporting accident), it causes the rupturing of muscle fibres at or adjacent to the 
impact area, and depending on the injury severity, the underlying vasculature may 
also be disrupted.  Neutrophils first infiltrate the damaged area, followed by 
macrophages, both of which generate free radicals, causing the area of necrosis to 
extend to affect uninjured tissue as well.  Satellite cells become activated by 
cytokines, growth factors and by the reactive species (generated by macrophages), 
whereafter they start to proliferate, fuse and form myoblasts.  These myoblasts 
proliferate, differentiate, and fuse with the damaged fibres to repair them.   
 
Currently there are many ways in which to accelerate the healing process after 
injury, mostly focussing on enhancing regeneration and minimizing fibrosis so as to 
reduce the amount of scar tissue formed within the muscle.  The ideal treatment for 
muscle contusions remains elusive, due to the fact that injuries of different severities 
can occur and due to the many different role players in the response to injury.  A 
single treatment is unlikely to prove optimal for all cases of contusion injury.  Rather, 
complementary groups of treatments should be considered.  The use of antioxidants, 
to scavenge reactive species (expression of free radicals over and above the 
quantity needed for the repair process) in particular Oxiprovin™ might prove a 
reliable method of treating contusion injuries, by reducing additional secondary 
damage. 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za 
 49
1.7  Aims 
Given the positive results reported in the literature about flavonoids and their various 
beneficial effects on the body, we hypothesise that Oxiprovin™ (part of the flavonoid 
family) supplementation will improve the speed of muscle recovery after a contusion 
injury. 
 
Therefore, the main aims of this study are: 
(a) to induce a standardised skeletal muscle contusion injury in rats using a non-
invasive technique, 
(b) to determine the effects of long term (both prior to and after injury) oral GSE 
supplementation on total body antioxidant status, by assessment of snap-frozen 
muscle samples and plasma samples using the ORAC assay, 
(e) to determine the effects of long term (both prior to and after injury) oral GSE 
supplementation on muscle physiology through immunohistochemical staining of 
satellite cells with CD34, CD56 and M-cad, and immunohistochemical staining of 
regenerating muscle fibres with foetal myosin heavy chain (MHCf). 
 
 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za 
 50
CHAPTER 2:  MATERIALS AND METHODS 
 
2.1  Study design 
2.1.1  Experimental animals 
All experimental protocols were approved by the Animal Ethics Committee of Sub-
Committee B of Stellenbosch University (project # 2006 Smith01).  Male Wistar rats 
were used for this study.  Animals were bred and housed in the Small Animal Unit in 
the Department Physiological Sciences at Stellenbosch University.  Animals were 
divided and housed in groups of four for the duration of the study, starting at the age 
of three weeks once weaned.  All animals had access to food (standard rat chow – 
supplied by the Medical Research Council animal unit, Parow) and tap water ad 
libitum and were exposed to a 12 hr light/dark cycle (lights on at 6:30).  Ambient 
temperature was controlled at 21 ºC, and rooms ventilated at 10 changes/hour.   
 
A couple of preventative measures were taken to minimise possible influences by 
confounding factors.  Firstly, rats were handled and weighed (twice daily) to ensure 
that at the start of the supplementation and injury protocols, rats were accustomed to 
the specific researcher.  Secondly, rats were orally gavaged with tap water (weight in 
µl) 2 weeks prior to the onset of the injury protocol, to habituate them to this 
procedure prior to supplementation with the grape seed extract (GSE).  All rats were 
allowed to reach maturity (± 7 weeks; mean weight of 286.6 ± 23.5 g), before 
subjection to any intervention.   
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2.1.2  Experimental groups  
Preceding the onset of the supplementation protocol and contusion injury, 
experimental rats were randomly divided into 4 groups: 
 
A) Non-injured rats receiving 2 weeks of placebo (C-P, n=8) 
B) Non-injured rats receiving 2 weeks of GSE supplementation (C-GSE, n=8) 
C) Rats injured after 2 weeks of placebo supplementation, with continued placebo 
supplementation post-injury (I-P; n=32, i.e. 8 rats per time point, time points were 
4 hr, 3 d, 7 d and 14 d post-injury) 
D) Rats injured after 2 weeks of GSE supplementation, with continued GSE 
supplementation post-injury (I-GSE; n=32, i.e. 8 rats per time point, time points 
were 4 hr, 3 d, 7 d and 14 d post-injury) 
 
Refer to section 2.1.3 for details on the preparation of the supplement and placebo. 
 
2.1.3  Intervention protocols 
The study included 2 intervention protocols, namely the supplementation and the 
injury.  Briefly, the 2-week supplementation intervention was followed by the mass-
drop contusion injury, after which blood and muscle samples were collected at 
different time points during recovery from injury for subsequent analysis.  
Supplementation with GSE or placebo was continued throughout the protocol up to 
sacrifice.   The study design is outlined in Figure 2.1. 
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2.1.3.1  Supplementation 
Preparation:  The 20 mg/kg/day GSE (Oxiprovin™) was prepared early in the 
morning, before supplementation.  Briefly, 20 mg of GSE was dissolved in 1 ml of 0.9 
% saline.  0.9 % saline was used as vehicle for the placebo rats. 
 
Administration:  Rats were orally gavaged with either 20 mg/kg/day GSE or 0.9 % 
saline for the duration of the experimental procedure.  Control (C) rats were gavaged 
for 2 weeks without injury and contusion injury groups received GSE or placebo for 2 
weeks prior to injury as well as after injury (Figure 2.1). 
 
2.1.3.2  Injury  
Apparatus:  Contusion of the hind limb was produced by an apparatus (Figure 2.2), 
designed and manufactured especially for our study in collaboration with the Central 
Engineering Services, Stellenbosch University.  In short, the lower part of the 
apparatus comprised a large round metal platform, with a small cylindrical platform in 
the centre on which the hind limb of the animal rested just prior to and during injury.  
A plastic tube fastened perpendicularly to and directly above the smaller platform 
directed the passage of the 200 g weight from the desired height to the area of the 
muscle identified for injury.  A peg through a hole in the plastic tube kept the mass in 
place at the desired height above the muscle, so that its removal resulted in a 
standardised mass dropping speed.  
 
Procedure:  All injury groups were gavaged for 2 weeks, after which they were 
anaesthetised (75 mg/kg ketamine, 0.5 mg/kg medetomidine and 0.9 % saline; 1 
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Figure 2.1:  Study design. 
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Figure 2.2:  The muscle contusion injury jig. 
 
 
ml/kg body weight i.p.).  The right hind limb of the animal was placed on the platform, 
and moderately extended away from the animal, to prevent injuring the underlying 
bone.  Injury was produced by dropping a weight with a mass of 200 g (through the 
plastic tube) from a height of 50 cm onto the medial surface of the right 
gastrocnemius muscle.  The weight dropped had a flat, circular impact surface, with 
a diameter of 1 cm, therefore an impact area of 0.785 cm2 that directly contacted the 
skin.  Directly post-injury, rats were allowed to recover under infrared lights until fully 
conscious. 
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2.2  Sacrifice and sample collection 
2.2.1  Sacrifice 
Entrance of rats into the intervention protocols was staggered, so that no more than 
9 rats were sacrificed per day.  All sacrifice procedures took place between 08:00 
and 10:00 in the morning.  With exception of the 4 hr injury time point, all rats were 
sacrificed 24 hr after the last intervention procedure.  All experimental animals 
received an overdose of pentobarbitone sodium (200 mg/kg i.p.).  On day 0, control 
rats were sacrificed (i.e. after 14 days of supplementation or placebo).  Eight rats 
from each of the 2 injury groups (I-P and I-GSE), were sacrificed at each of the 
following time points after subjection to hindlimb muscle contusion injury (4 hr, on 
day 3, 7 and 14 after injury).  After sacrifice, the right injured gastrocnemius muscle 
was excised (see section 2.2.2.2) and whole blood samples obtained (see section 
2.2.2.1).   
 
2.2.2 Sample collection 
2.2.2.1  Blood collection 
Following euthanasia by pentobarbitone overdose, the heart was exposed by 
opening the chest cavity.  Whole blood samples were obtained by means of right 
ventricular cardiac puncture.  Blood was collected using a 20 gauge, 1½ inch needle 
into a 5 ml syringe and immediately transferred to heparinised tubes (Vacutainer, 
Beckton Dickinson).  Blood samples were immediately mixed and placed on ice prior 
to centrifugation (within 2 hr) at 3000 g for 10 minutes at 4 C.  Plasma obtained was 
aliquoted into 1.5 ml reaction vials and stored at -80 C until subsequent analysis.  
Batches of plasma were used to analyse CK activity as an indirect indicator of 
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muscle damage (see section 2.3.1) [239]. For ORAC analysis, which was used to 
determine the oxygen radical absorbance capacity, plasma samples were kept 
frozen for no longer than 1 to 1½ weeks after collection before analysis.   
 
2.2.2.2  Muscle collection 
After the procedures for cardiac puncture, but within 5 minutes of euthanase 
administration, the gastrocnemius muscle of the right hind leg was exposed by 
cutting and removing the skin and connective tissue surrounding the muscle.  The 
medial central section of the gastrocnemius muscle (Figure 2.3) was harvested by 
cutting away the unwanted muscle after which this section was divided into two, so 
that one part was processed for immunohistochemistry (see section 2.3.3), and the 
other snap-frozen for biochemical analysis. 
  
 
 
 
 
 
 
 
Figure 2.3:  The gastrocnemius muscle complex with grid superimposed to indicate 
cutting during the harvesting process.  The central medial (hatched) section was 
used for analysis. 
 
 
 
 
 
 
Snap-frozen in liquid nitrogen – 
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2.3  Sample analysis 
Four different analytical procedures were used:  a) creatine kinase (CK) activity 
assays performed on plasma, b) ORAC assays performed on both plasma and snap-
frozen muscle tissue, c) histological staining and visualisation of muscle sections and 
d) immunohistochemical analysis of muscle sections. 
 
2.3.1  CK activity 
Total CK, as an indicator of the presence of muscle damage, was determined by 
PathCare pathology laboratory (Vergelegen Medi Clinic, Somerset West, South 
Africa) using an automated enzymatic method.  The normal range of serum CK 
activity is 15 – 195 u/L (at 37 oC).     
 
2.3.2  Oxygen radical absorbance capacity (ORAC) assay 
The ORAC assay was performed on plasma using the method of Huang et al. (2002) 
no later than 10 days after sample collection, because the antioxidants present in the 
sample decrease with time. The ORAC assay is based on the measurement of free 
radical-induced quenching of a fluorescent probe.  Through the change in the 
fluorescence intensity of the probe in solution over time, an index of the extent of 
free radical quenching capacity of the probe in the sample solution can be 
determined. In the presence of antioxidants, free radical-induced quenching of the 
probe is inhibited, and the extent of delay in quenching reflects the antioxidant 
capacity of the sample and is called the ORAC [170–174].  After antioxidant 
supplementation, a higher ORAC compared to the controls is expected.  The ORAC 
assay procedure is identical for assessment of plasma/serum or tissue 
homogenates.  See appendix A for summary of reagents and laboratory method.   
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2.3.2.1  Standard preparation 
6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) was used as 
standard.  To generate the standard curve, the following Trolox standards were 
prepared in 75 mM phosphate buffer, pH 7.4:  50, 25, 12.5 and 6.25 µM.     
 
2.3.2.2  Solution and sample preparation 
A fresh 153 mM 2,2’-Azobis-(2-methylpropionamidine)-dihydrochloride (AAPH) 
working solution was made, by completely dissolving 0.414 g AAPH in 10 ml 
phosphate buffer (75 mM, pH 7.4) and then kept on ice.  Fluorescein stock solution 
(5x10-3 nM) was made in 75 mM phosphate buffer (pH 7.4) and was kept at 4 ºC in 
dark conditions.  The fluorescein stock solution, if stored appropriately, can last for 
several months [238].  A 8.16x10-5 mM fluorescein working solution was made daily 
by further diluting the stock solution in 75 mM phosphate buffer (pH 7.4).  Plasma 
samples were defrosted and diluted 75x (personal communication: Dr. Dee 
Blackhurst, Cape Town University) in 75 mM phosphate buffer, pH 7.4.  
 
Crude tissue extracts were prepared by adding approximately 10 mg of the snap-
frozen muscle tissue to 75 mM phosphate buffer (pH 7.4) (1:75 w/v).  The tissue 
samples were sonicated on ice for approximately 1 minute continuously with a tissue 
sonicator (Virsonic 300; The Virtis Company, Inc; Gardiner, N.Y; setting 3), 
whereafter, the homogenates were centrifuged for 30 min at 8853 g (12000 RPM) at 
4 °C with a multispeed refrigerated centrifuge (model: PK121R centrifuge, brand: 
ALC international SRL, Milano, Italy) and the supernatant immediately used for the 
ORAC assay. The values obtained after performing the ORAC assay on the muscle 
were standardised for protein by determination of total protein concentration of the 
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muscle supernatants used, by means of the Bradford assay [240] (described in 
Appendix B).  Results for ORAC were expressed as µmol Trolox equivalents/µg 
protein. 
 
2.3.2.3  Analytical method 
The figure in Appendix A illustrates the 96-well plate used for the ORAC assay.  The 
quantity of blank, standard or sample per well was 25 µl added in triplicate to their 
respective wells, as well as 150 µl of the Fluorescein working solution.  The plate 
was then covered and allowed to equilibrate for 10 minutes at 37ºC in the 
fluorometer, whereafter 25 µl of the AAPH solution was added for the reaction to 
start.  The fluorescence intensity of the solutions in all wells was read 36 times, at 
one minute intervals according to the method of Huang et al. (2002). 
 
2.3.2.4  Calculation of the ORAC values 
The net area under the curve (AUC) of all standards and samples were calculated by 
plotting time (in minutes) against relative fluorescence intensity (Figure 2.4).  The 
standard curve is obtained by plotting the four different Trolox standard 
concentrations against the average net AUC of these standards (Figure 2.5).  The 
final ORAC values are calculated using the regression equation between Trolox 
concentration and the net AUC and are expressed as µmol Trolox equivalents per 
liter for liquid samples (plasma) and µmol Trolox equivalents per µg protein for solid 
samples (homogenised muscle).   
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The AUC was calculated using Microsoft Excel XP as 
 
0.5 + ƒ1/ƒ0 + … ƒi/ƒ0 + … + ƒ34/ƒ0 + ƒ35/ƒ0                                                     (1)                                       
 
where ƒ0 = initial fluorescence reading at 0 minutes and ƒi = fluorescence reading at 
time i.   
 
The net AUC is obtained for all the samples, by subtracting the AUC of the blank 
from that of a sample or a Trolox standard.  
 
Net AUC = [(AUCsample or Trolox – AUCblank)                                                      (2)                 
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Figure 2.4:  An illustration of the calculation of the net AUC, calculated as difference 
in fluorescence of the Blank and the Trolox standards or samples. 
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The standard curve is obtained by plotting Trolox concentrations against the average 
net AUC of the Trolox standards.  An example is illustrated in Figure 2.5.  Final 
ORAC values are calculated using the regression equation between Trolox 
concentration and the net AUC and are expressed as µmol Trolox equivalents per 
liter.  It should be noted that the dilution factor (in this study it was 75x) needs to be 
included for final ORAC value calculation.  For the muscle samples, the ORAC 
values were obtained in the same way as that for the plasma samples, but in 
addition, the ORAC value was divided by the protein concentration determined using 
the Bradford assay (Appendix B).   
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Figure 2.5:  Example of the linear relationship between net area under the 
fluorescence decay curve and the Trolox concentrations. 
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2.3.3  Histology 
One representative muscle sample from each of the 4 experimental groups was 
preserved in 10 % formaldehyde-saline for 72 hours.  The samples were then cut to 
size, placed into embedding cassettes, processed and impregnated with paraffin wax 
(Histosec, Merck) (see Appendix C for details of tissue processing) using an 
automated tissue processor (TISSUE TEK II, model 4640B, Lab-Tek division, Miles 
Laboratories Inc, Naperville, IL).  Impregnated tissue samples were embedded in 
paraffin wax.  Five µm cross-sections were cut using a rotary microtome (Reichert 
Jung, Heidelberg, Austria) and stained with haematoxylin and eosin (H&E – see 
Appendix D for detailed method) to visualise subjectively the extent of immune cell 
infiltration into the injured area. 
 
2.3.3.1  H&E staining 
The tissue used for H&E staining is embedded in paraffin wax, and, in order for 
water soluble dyes to penetrate the tissue sections, the slides are deparaffinized and 
rehydrated (Appendix D) [241].  Haematoxylin stains the basophilic structures blue-
purple and alcohol-based eosin stains the eosinophilic structures bright pink.  The 
basophilic structures usually contain nucleic acids, such as ribosomes and cell 
nuclei, and cytoplasmic regions rich in RNA.  The eosinophilic structures are intra- or 
extracellular proteins (mostly cytoplasm and red blood cells).  
   
2.3.4  Immunohistochemistry 
2.3.4.1  Reagents 
The antibodies used for immunohistochemistry, are summarised in Table 2.1. 
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Table 2.1:  Antibodies used to identify vascular endothelium (CD31), satellite cells 
(CD34, CD56, M-cadherin), and regenerating skeletal muscle fibres (MHCf). 
 
Antibodies 
 
[Stock] 
(µg/ml) 
Dilution Catalog # and supplier  
Primary antibodies: 
 
   
Monoclonal mouse anti-human 
CD31 (JC70A) 
 1/100 M0823, Dako 
Monoclonal mouse anti-human 
CD34 (ICO115) 
100 1/100 sc-7324, Santa Cruz 
Polyclonal rabbit anti-human NCAM 
(H-94)  
1.7 x 105 1/100 sc-8305, Santa Cruz 
Mouse anti-human foetal myosin 
heavy chain (MHCf) 
 1/25 F1.652-s, Developmental 
Studies Hybridoma Bank  
Polyclonal rabbit anti-human M-
cadherin (H-71) 
200 1/100 sc-10734, Santa Cruz 
    
Biotinylated secondary 
antibodies: 
   
Donkey anti-rabbit 1.3 x 103 1/1200 711-065-152, Jackson 
ImmunoResearch  
Donkey anti-mouse 1.3 x 103 1/1000 715-065-150, Jackson 
ImmunoResearch  
    
Tertiary antibodies: 
 
   
Fluorescein Streptavidin (FITC) 
 
 1/500 SA-5001, Vector 
Laboratories  
Texas Red Streptavidin 
 
 1/500 SA-5006, Vector 
Laboratories 
 
 
2.3.4.2  Procedure 
Slides, each containing three serial sections per slide for each sample were labelled 
using each of the following markers:  CD31 (staining the vascular endothelium – 
used only in the pilot study discussed in section 2.6), CD34 (satellite cells), CD56 
(satellite cells), M-cadherin (satellite cells) and foetal myosin heavy chain (MHCf –
regenerating skeletal muscle fibres).  All dilutions were made with phosphate-
buffered saline (PBS).  Sections stained for CD34 were co-stained with CD56 and M-
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cadherin, whilst MHCf and CD31, were used as individual markers.  Slides were first 
taken through a conventional rehydration sequence followed by 0.1 % trypsin at 37 
°C for 20 minutes prior to immunostaining (See Appendix E for detail).  The 
immunostaining procedure for paraffin sections is summarised in Appendix F.  
Briefly, slides were dried, and sections were encircled with a wax pen.  Non-specific 
binding sites were blocked by incubating the sections with 5 % donkey serum at 
room temperature for 30 minutes.   The serum was then drained off and primary 
antibody added to the slides and left for 4 hours at room temperature.  Slides were 
washed with 0.1 M PBS (1 ℓ of 1 M phosphate buffer, 90 g NaCl, 9 ℓ ddH2O; pH 7.4) 
prior to addition of biotinylated secondary antibody (1/1200 anti-rabbit, 1/1000 anti-
mouse), raised in donkey.  After 40 minutes of incubation, slides were washed with 
PBS and then the tertiary antibody (1/500) was added and left for 30 minutes at 
room temperature followed by the addition of the nuclear stain, Hoechst (1/200), for 
10 minutes.    To co-stain, either M-cadherin (1/100) or CD56 (1/100) were added to 
different CD34-stained slides and incubated overnight at 4 oC.  The following 
morning slides were washed as previously described before incubation with a 
biotinylated secondary antibody raised in donkey (1/1200) for 40 minutes.  Slides 
were washed 3 times in PBS before adding Texas Red-labelled antibody (1/500) for 
30 minutes at room temperature.  The nuclear marker was added as previously 
described before washing with PBS and mounting the slides with fluorescent 
mounting medium (Dako, Diagnostech).  During the whole staining protocol, slides 
were kept in the dark in a humidified environment.  PBS controls were used to test 
the specificity of the antibodies. 
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2.3.4.3  Image analysis 
All imaging data were obtained by analysing two serial sections (5 μm apart) from 
each muscle sample, at each time point for each antibody.  Six fields of view per 
section were imaged using a microscope (Nikon ECLIPSE E400; 400x objective 
used), equipped with a colour digital camera (Nikon DXM1200).    Photos were used 
to count positively stained satellite cells as well as the total number of muscle fibres 
and regenerating muscle fibres per field of view using a computer programme 
(Simple PCI version 4.0, Compix Inc., Imaging Systems, USA).  If necessary, photos 
were enlarged and the color of the stain enhanced after importation into Simple PCI 
to assist with identification. The images displayed are only partial images of those 
taken at 400x.  All photos of injured muscle were taken at borderline zones, next to 
the severely injured areas.  Satellite cell data were expressed as the number of 
satellite cells per myofibre, whereas MHCf data were expressed as the percentage of 
regenerated myofibres per total myofibre count in the viewed area. 
 
CD34:  CD34 expression in muscle sections was quantified as the number of CD34+ 
satellite cells per myofibre number.  Due to the fact that other cells, including 
fibroblasts and hematopoeitic cells, also express CD34, only CD34+ cells in contact 
with the sarcolemma and causing an indentation in the myofibre, were recorded as 
CD34+ satellite cells (Figure 2.6, yellow arrows).  When more than one nucleus was 
present in the satellite cell pocket, each one of these satellite cells was counted 
individually.  The nuclei of the CD34+ cells which did not make an indentation in a 
myofibre in most cases appeared round and/or were situated clearly outside the 
myofibrillar space. Alternatively, some cells made an indentation, but CD34 staining  
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Figure 2.6:  CD34 staining in a biopsy of the uninjured gastrocnemius muscle 
(original magnification x 400).  Figure 2.6A represent a PBS control.  Figures 2.6B 
and C indicate CD34 expression visualised by FITC (green) alone, or FITC and 
Hoechst (blue – stains all nuclei) respectively.  The yellow arrows indicate CD34+ 
satellite cells whereas the white arrows demonstrate CD34+ cells not identified as 
satellite cells (see text).  Scale bar represents 10 µm.  
 
B
C
A
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was not intense enough, or the nucleus was absent.  These cells, although CD34+, 
were not counted (Figure 2.6, white arrows). 
 
CD56:  CD56 was used as a marker to investigate the number of activated satellite 
cells [144].  The identification of satellite cells with this specific marker, was done 
making use of the same criteria discussed in the previous section using CD34 as a 
satellite cell marker.  
 
M-cadherin:  M-cadherin does not stain all satellite cells, but it does stain most 
quiescent, activating and proliferating satellite cells [121, 123, 125].  Counting of 
satellite cells stained positive for M-cadherin was done using the same criteria as 
counting satellite cells stained for CD34. 
 
Foetal myosin heavy chain (MHCf):  Using the MHCf antibody, one can distinguish 
between adult muscle fibres and newly formed or regenerating muscle fibres [242].  
The number of foetal or regenerating muscle fibres that are formed after sustaining a 
contusion injury are expressed as a percentage of the total number of muscle fibres 
viewed (all muscle fibres = adult + foetal).  Identifying fibres positive for this particular 
antibody can be problematic, as it labels not only the foetal muscle fibres, but some 
mature fibres as well.  To be counted as MHCf+, the staining inside the muscle fibre 
had to comply with the following criteria:  i)  At least 3 or more sides of the muscle 
fibre had to be either bright green (if FITC labelled secondary was used) or bright red 
(if Texas red labelled secondary was used), ii)  Central nuclei must be present inside 
the fibre, iii)  The positively stained fibre also had to have a somewhat hazy shade 
compared to the other fibres.  Figure 2.7 illustrates labelling with MHCf. 
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Figure 2.7:  Foetal myosin heavy chain (MHCf) staining of newly formed muscle 
fibres or regenerating muscle fibres.  Panel A is a representative PBS control.  FITC 
(green) is visualized in Panel B, and FITC and Hoechst (blue – stains all nuclei) in 
Panel C (original magnification x 400).  Images taken of borderzone areas from 
muscle sections from a GSE supplemented rat, 3 d after injury.  The yellow circles in 
image B represent the fibres positive for MHCf, however, only the muscle fibres in 
image C are truly regarded as being MHCf+, due to the presence of central nuclei.  
Scale bar represents 10 µm.   
A B
C
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2.4  Statistical analysis 
A regression analysis was performed to compare growth curves in the different 
experimental groups. Differences between time points for other results were 
analysed using factorial analysis of variance (ANOVA) with Bonferonni post hoc tests 
and an unpaired, two-tailed student t-test for comparison of ORAC data between the 
control groups.  All statistical analyses were done using the computer software 
Statistica version 7 (StatSoft Software), with the exception of CK AUC, which was 
determined using NCSS 2000. The accepted level of significance was p < 0.05.  All 
results are reported as means ± standard deviation (SD), unless otherwise specified. 
 
 
2.5  Additional experimental issues 
Due to the variability in methods reported in the literature to achieve a contusion 
injury, it was necessary to optimise the experimental procedure.  In order to achieve 
this, two pilot studies were carried out.  These are discussed below in section 2.6.   
 
 
2.6.1  Pilot 1: Injury optimisation in terms of drop distance  
2.6.1.1  Introduction 
The drop distance needed to be optimised in order to determine which height would 
give a moderately severe contusion injury, but not as severe as the injuries obtained 
with e.g. compartment syndrome or cryoinjury, to investigate muscle recovery.  
Muscle recovery includes two possible ways in which the fibres can heal.  Firstly, 
there is recovery of injured fibres, i.e. regeneration of already existing fibres, and 
secondly there is formation of completely new fibres.  Recovery from a contusion 
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injury in our model, is likely to include a combination of both newly generated muscle 
fibres, as well as regenerated muscle fibres, however, because we investigated 
cross-sections (example in Figure 2.8), we cannot distinguish between the two types 
of fibre repair mentioned. 
 
2.6.1.2  Methods 
Following anaesthesia (75 mg/kg ketamine, 0.5 mg/kg medetomidine and 0.9 % 
saline; 1 ml/kg body weight i.p.), 13 male Wistar rats (367.5 ± 17.7 g) received either 
a severe injury (SI – n=6), mild injury (MI – n=3) or sham injury (C – n=4) to their 
right gastrocnemius muscle.  Drop distances were 50 cm for SI and 25 cm for MI, the 
weight used had a mass of 200 g in both groups.  Rats were sacrificed 3 days after 
the injury intervention by overdose of pentobarbitone sodium (200 mg/kg i.p.), 
whereafter the medial central part of the gastrocnemius muscle complexes were 
harvested, and fixed in 10% formaldehyde, processed, and wax blocks prepared as 
described earlier.  Muscle sections (5 µm) were stained with H&E and examined 
using light microscopy for signs of immune cell infiltration and tissue disruption.  In 
order to also investigate the extent of vascular disruption, sections were stained with 
CD31, the vascular endothelial marker.  
 
2.6.1.3  Results 
No quantitative data were obtained for the images captured.  H&E stains are 
presented in row 1 of Figure 2.8, whilst row 2 contains phase contrast images 
showing the outlines of the muscle fibres, whilst the images in row 3 indicate 
fluorescent labelling using CD31 (see appendix F and section 2.3.3 for 
immunohistochemistry).  The columns represent the 3 different groups, with the  
Stellenbosch University  http://scholar.sun.ac.za 
 71
 
 
Figure 2.8:  The gastrocnemius muscle 3 days post injury.  The columns indicate the 
following: (A) uninjured transverse section; (B) injured transverse section (weight of 
200 g from a distance of 25 cm) and (C) injured transverse section (weight of 200 g 
from a distance of 50 cm).  The rows indicate the following:  (1) H&E stain; (2) phase 
contrast indicating the outline of the muscle fibres; and (3) fluorescent staining with 
CD31 (capillary endothelial marker – green) and Hoechst (nuclear stain – blue). 
Original magnification (x 400). 
 
  
 
control (C) group in column A, the mild injury (MI) group in column B and severely 
injured (SI) group in column C.  Image A1, a section of the uninjured gastrocnemius 
muscle, illustrates normal skeletal muscle fibre ultrastructure.  When compared to 
images A1 and B1, it can be seen that a more profound immune cell infiltration 
A B C 
1 
2 
3 
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accompanied the total disruption of the muscle fibre ultrastructure in image C1.  In 
image B1 and B2, only mild disruption of skeletal muscle fibre ultrastructure is 
visible, as well as a small amount of immune cell infiltration.    In image C3, the large 
degree of vascular disruption is apparent.  As a result of these findings, the height of 
50 cm was chosen as the optimal height for the purpose of this contusion injury 
experiment. 
 
2.6.2  Pilot 2:  Grape seed extract (GSE) dose determination  
2.6.2.1  Introduction 
The recommended method of supplementation with grape seed extract (GSE) is by 
daily oral intake of two tablets, each containing 70 mg proanthocyanidin.  Assuming 
a standard human body mass of 70 kg, this translates to a dose of 2 mg/kg/day.  
Taking into account the higher metabolic rate of rats relative to humans, it was 
possible that the 2 mg/kg/day dose of GSE would not be sufficient to allow sustained 
detection of GSE in rats.  Therefore, we investigated supplementation with various 
concentrations of the extract.   
 
2.6.2.2  Methods 
Rats were divided into four groups of 3 rats each.  Rats received either the 
prescribed dose for humans of 2 mg/kg/day GSE (n = 3), or higher doses of 10 
mg/kg/day GSE (n = 3) or 20 mg/kg/day GSE (n = 3), or placebo (0.9 % saline, n = 
3) administered by oral gavage once daily.  Supplementation with GSE or placebo 
was started once animals reached maturity (i.e. at about 7 weeks of age) and was 
administered for 14 days.  Rats were sacrificed 24 hr after last gavage and whole 
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blood collected by cardiac puncture into heparinized tubes for determination of the 
oxygen radical absorbance capacity (ORAC assay – see section 2.4.1).  
 
2.6.2.3  Statistical analysis 
Data were analysed using one-way analysis of variance (ANOVA) with Bonferonni 
post hoc test.  The accepted level of significance was p < 0.05.  All results are 
reported as means ± standard error of the mean (SEM), unless otherwise specified.  
Statistical analysis for this particular pilot study was done with the aid of the 
computer software Prism version 2.01 (GraphPad Software Inc, San Diego, 
California, USA). 
 
2.6.2.4  Results 
Figure 2.9 illustrates the different dosages of GSE and placebo (supplement) on the 
x-axis plotted against the ORAC value (µg Trolox equiv/ℓ) on the y-axis.  The free 
radical scavenging capacity of the plasma was higher when GSE was administered 
to the rats at a dose of 20 mg/kg/day compared to the free radical scavenging effects 
of the 10 mg/kg/day and 2 mg/kg/day doses.  There were significant differences 
between the 20 mg/kg/day GSE groups and all the other groups receiving either a 
lower dose of GSE or 0.9 % saline (see Figure 2.9).  There was also a significant 
difference between the 10 mg/kg/day and the 0.9 % saline (p < 0.01).  However, 
there was no statistically significant difference between the 2 mg/kg/day GSE and 
the saline group.  Furthermore, as a result of the data obtained and due to the fact 
that the metabolic rate of rats is 7-10 times quicker than that of humans, the 20 
mg/kg/day dose was chosen.   
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Figure 2.9:  ORAC results of the second pilot study, determining the response to 3 
concentrations of GSE.  Data are indicated as mean ± SD (* p < 0.05, ** p < 0.01, *** 
p < 0.001). 
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CHAPTER 3:  RESULTS 
 
 
Results of all figures are given as mean ± SD, unless otherwise indicated.  Data 
presented graphically are also present in Tables in Appendix G.   
 
 
3.1  Body mass 
The daily averages for body mass of both the injury and control GSE and placebo 
groups are illustrated in Figure 3.1.     
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Figure 3.1:  Daily body mass, with n = 8 rats per time point per group. 
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When regression analysis was performed on the same data for time points prior to 
injury (Figure 3.2), the C-P group displayed a steeper slope compared to the other 
groups.  However, since this group was neither injured or GSE treated, this 
difference, which may indicate a slightly higher metabolic rate in this group, should 
not influence other results obtained.  It should also be noted that directly following 
the contusion injury (Figure 3.1), there was a decrease in body mass in both the 
placebo and GSE groups, but this initial body mass loss was regained by day 1 after 
injury, whereafter rats continued to gain body mass until sacrifice.   
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Figure 3.2:  Differences in growth over time.  The dots represent the slope and the 
bars represent 95% confidence intervals of all groups.  Statistics:  Multiple 
regression analysis, n = 8 rats per time point per group.   
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Table 3.1 indicates the average body mass of all four groups at two specific time 
points prior to sacrifice/injury.  A main effect of time was apparent for all treatment 
groups before sacrifice/injury (p < 0.001).  Over the 7 day period during which all 
groups were subjected to daily gavage, mean increases in body mass were similar 
for C-GSE, I-P and I-GSE and ranged from 36.2g (I-GSE) to 40.3 (I-P), whereas only 
C-P increased significantly (p < 0.01).   
 
Table 3.1:  Body mass (g) prior to injury. 
 
Intervention time C-P C-GSE I-P I-GSE 
Gavaging (2 wk pre-injury) 272.3 ± 20.0** 276.0 ± 30.3 306.8 ± 19.8 291.3 ± 7.5 
Gavaging (1 wk pre-injury) 333.8 ± 20.9 313.5 ± 22.2 346.5 ± 22.1 327.5 ± 3.9 
 
Data presented as mean  SD.  Abbreviations: Control Placebo (C-P), Control GSE (C-GSE), 
Injury Placebo (I-P), Injury GSE (I-GSE).  Statistics:  Factorial analysis of variance (ANOVA) 
with Bonferonni post hoc test. ** p < 0.01 for difference in the C-P group between 2 wk and 1 
wk to injury. n = 8 rats per time point per group. 
 
Table 3.2 indicates the average body mass of both injury groups at different time 
points following contusion injury.  After injury, a main effect of time and treatment (p 
< 0.001 for both) were visible between the two groups.  However, the main effect of 
treatment was the result of a consistent difference in mean body mass of the 
randomly divided groups at the start of the experimental procedures (Figure 3.1) that 
remained fairly consistent throughout ranging between 14 and 23 g.  Seven days 
after injury, there was a significant difference in body mass in the placebo group 
compared to body mass before injury (p < 0.05).  In the GSE group, a significant 
difference in body mass was only apparent 14 days after injury compared to before 
injury (p < 0.001).     
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Table 3.2:  Body mass (g) after injury.  
 
Intervention times I-P I-GSE 
Before injury 374.5 ± 18.9 360.5 ± 15.7 
4 hr after injury 370.5 ± 20.2 354.3 ± 10.0 
3 days after injury 392.0 ± 16.1 377.0 ± 6.8 
7 days after injury 418.5 ± 18.1 395.0 ± 2.6 
14 days after injury 437.3 ± 17.2 416.5 ± 13.4 
 
Data presented as mean  SD.  Abbreviations: Injury Placebo (I-P), Injury GSE (I-GSE).  
Statistics:  Factorial analysis of variance (ANOVA) with Bonferonni post hoc test.  n = 8 rats 
per time point per group.   
 
 
3.2  Creatine kinase activity 
Main effects ANOVA indicated significant differences in plasma CK levels over time 
(p < 0.05), but there were no differences between treatment groups at any time 
point.  Figure 3.3, suggests a transient increase in CK levels 4 hr post-injury in both 
the treatment groups.  However, when comparing 4 hr post-injury time points to all 
other time points, post hoc analysis only indicated significant differences in the GSE 
group.  In contrast to the higher initial CK level of the GSE group, when AUC of 
plasma CK was calculated, the placebo group displayed a 56 % greater AUC over 
time than the GSE group (Figure 3.4). 
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Figure 3.3:  Total plasma creatine kinase (CK) activity (mean  SD) of the control 
non-injured groups and the injury groups at several time points after the contusion 
injury.  Statistical analysis:  Factorial analysis of variance (ANOVA) with Bonferroni 
post hoc test (* p < 0.05 for the 4 hr time point compared to all other time points of 
the GSE group, except control).  Main effect of time, p < 0.05. n = 4 rats per time 
point per group. 
 
 
 
3.3  Haematoxylin and eosin staining 
Figure 3.5 illustrates histological staining with haematoxylin and eosin.  Using this 
staining technique, qualitative changes in the muscle can be visualised over time.  In 
the control groups (A and F), no muscle fibre ultrastructure damage is apparent.  
Soon after injury (4 hr, B and G), the disruption of the muscle fibre ultrastructure was 
accompanied by vascular disruption and immune cell infiltration in both the treatment 
groups.  A qualitative assessment of day 3, resulted in an estimation of more 
Non-injured Post-injury
*
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Figure 3.4: AUC of plasma CK calculated for all time points in the placebo group 
and the GSE group.  n = 4 rats per time point per group.  AUC was calculated using 
NCSS 2000. 
 
 
immune cells and less vascular damage at this time (C and H).  It would appear that 
at this time point, in the GSE group (H) the immune cell infiltrated area was 
surrounded by newly formed/regenerating muscle fibres.  In the placebo group on 
the other hand, newly formed/regenerating muscle fibres were only apparent 7 days 
post-injury (D).  By day 14, the GSE group’s muscle ultrastructure was normal (J), 
whereas a few immune cells were still present in the muscle fibres of the placebo 
group (E), and all fibres were not yet well connected. 
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                Before injury                           4 hr                                     3 d                                     7 d                                  14 d 
 
Figure 3.5:  H& E staining illustrating the clearing of inflammation after injury.  Photos A – E represent samples taken from 
placebo-treated animals at 14 d after gavaging began: before injury (A), 4 hr (B), 3 d (C), 7 d (D) and 14 d (E) post-injury.  
Photos F-J represent the same time points in the GSE group. Scale bar represents 10 µm.  Photo B and G represent muscle 
fibre destruction and vascular disruption.  Immune cells infiltrated the injured area (photo C and H).  New muscle fibres are 
formed by day 3 in the GSE group (H), whilst new muscle fibres are only formed by day 7 in the placebo group (D).  The GSE 
group (J) displayed normal muscle fibre ultrastucture 14 days after injury, whilst a small amount of immune cells were still 
present in the placebo group (E).   
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F G H I  J
81
Placebo 
GSE 
Stellenbosch University  http://scholar.sun.ac.za 
82 
3.4  The oxygen radical absorbance capacity (ORAC)  
Figure 3.6 illustrates the oxygen radical scavenging capacity of the control groups in 
the plasma and muscle.  Significant differences were noted in both the plasma 
(Panel A) and muscle (Panel B) between the placebo and GSE groups (p < 0.001).  
Figure 3.7 illustrates the free radical scavenging capacity of plasma from chronically 
supplemented rats sacrificed at various time points after injury, whereas Figure 3.8 
illustrates the muscle’s scavenging capacity. 
 
 
Figure 3.6:  Plasma (A) and muscle (B) oxygen radical absorbance capacity of the 
control groups (Figure detail:  *** p < 0.001).  Statistics:  Unpaired, two-tailed student 
t-test. n = 8 rats per group. 
 
 
 
Statistical analysis of the results of the plasma ORAC assay indicated a main effect 
of time (p < 0.05), but no main effect of treatment.  Post hoc analysis indicated no 
significant differences in the ORAC of the placebo group between any time points.  
However, 4 hr following the contusion injury, a significant decrease was seen in 
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ORAC in the GSE group compared to its non-injured control.  By day 3 after injury, 
ORAC increased significantly compared to early after injury, revealing a capacity 
equivalent to control values (p < 0.05).  Between the two treatment groups, the only 
significant difference was seen on day 3, when the GSE group had a higher ORAC 
value than the placebo group. 
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Figure 3.7:  Plasma oxygen radical absorbance capacity over time (Symbols:  * p < 
0.05, ** p < 0.01).  Statistics:  Factorial analysis of variance and Bonferonni post-hoc 
test. n = 8 rats per time point per group. 
 
 
In the muscle samples (Figure 3.8), statistical analysis of the ORAC assay results 
indicated a main effect of both time and treatment (p < 0.001).  A significant increase 
in ORAC was seen by day 7 post-injury in the placebo group compared to placebo 
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control.  The ORAC of the GSE group on the other hand had a similar pattern to that 
seen in the plasma.   Between the treatment groups, significant differences were 
noted by day 3, and day 14 post-injury where values similar to control values were 
reached.  ORAC values by day 7 were also similar to control.  
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Figure 3.9:  ORAC assay results from analysis performed on snap-frozen muscle 
sections of the gastrocnemius muscle (Figure detail: *** p < 0.001).  Statistics:  
Factorial analysis of variance and Bonferonni post-hoc test. n = 8 rats per time point 
per group. 
 
 
3.5  Satellite cell response to injury 
An overview of this section’s results indicates that satellite cell (SC) responses to 
injury were significant (main time effect), the presence of GSE affected the response 
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(main treatment effect) and interaction between time and treatment were seen at 
various time points (p < 0.001 for all marker antibodies used).  Detail for each marker 
follow. 
 
3.5.1  CD34 
The number of CD34+ SC per myofibre at different time points and for different 
groups is presented in Figure 3.9.  A main effect of time was seen (p < 0.001).  Four 
hours after injury, there was a significant 2.69-fold increase in the number of CD34+ 
SC per myofibre in the placebo injured (I-P) group compared to placebo control (C-
P).  A further increase in CD34+ SC numbers in the placebo group was seen on day  
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Figure 3.9:  CD34+ satellite cell (SC) count normalised for the myofibre number 
(SC/myofibre) (mean  SD).  Statistical analysis:  Factorial analysis of variance 
(ANOVA), with Bonferonni post-hoc test demonstrating significance between the two 
specific data points (** p < 0.01, *** p < 0.001). n = 4 rats per time point per group. 
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7 following injury at which time the increase was 4.62-fold higher than placebo 
control.  In the GSE group, CD34+ SC numbers also showed a significant increase at 
4 hr which in this case was already 5.38-fold, but by day 3, CD34+ SC in the GSE 
group had already significantly decreased to 3.51-fold above GSE control.  By day 
14, the CD34+ SC number returned to levels similar to control levels in both of the 
two treatment groups.  GSE treatment also had a main effect on CD34+ SC number 
(p < 0.001), which was most evident at two specific time points.  Although there were 
no differences between the two groups pre-injury, 4 hr after injury the GSE group 
had a significantly higher number of CD34+ SC than the placebo group, whereas on 
day 7, this pattern was reversed with the placebo group having more CD34+ SC at 
this later time point.  Representative images illustrating increased CD34 expression 
in the GSE and placebo groups are presented in Figure 3.10.  Control images are 
also included for comparison.    
 
3.5.2  CD56 
There was a main effect of time and treatment for CD56 expression (p < 0.001).  
Figure 3.11 indicates the differences between groups over time for the number of 
CD56+ SC.  There was a significant 4.19-fold increase in the number of CD56+ SC in 
the placebo group by day 3 after injury compared to the placebo control (p < 0.001).  
On day 7 the number of CD56+ SC was similar to that on day 3 for the placebo 
group, but by day 14, levels correlating to control levels were reached.  At this time 
point, the CD56 levels differed once again, significantly from those seen on day 7 (p 
< 0.001).  CD56 expression in the GSE group on the other hand showed a highly 
significant increase of 9.33-fold at the 4 hr after injury time point compared to its 
control (p < 0.001).  From 4 hr onwards, the GSE group had a gradual decrease in 
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Figure 3.10:  CD34 expression (green, FITC) in muscle samples taken at (B) 14 d 
after placebo treatment in the control group, (E) 4 hr post-injury in the injured leg of 
the GSE group and (H) 7 d post-injury for the placebo group.  The photos on the 
right hand side (C, F, I) correspond to the time points of the photos in the middle, 
representing merged images of CD34 expression and that of Hoechst (blue) that 
stains all nuclei (original magnification x 40).  PBS controls are presented in photos 
A, D and G.  CD34+ satellite cell examples are indicated by yellow arrows, whereas 
the white arrows indicate non-satellite cells.  Scale bar represents 10 µm.  Border 
zone images were analysed for injured muscle. 
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Figure 3.11:  CD56+ satellite cells expressed per myofibre number (CD56+ 
SC/myofibre number) (means  SD) at baseline (non-injured) and at 4 hr, day 3, 7 
and 14 post-injury.  Statistical analysis:  Factorial analysis of variance and 
Bonferonni post-hoc test (* p<0.05, *** p<0.001).  n = 4 rats per time point per group. 
 
 
 
the number of CD56+ SC until reaching levels similar to control levels on day 14.  
Treatment also had an effect, with a highly significant difference between the two 
groups at one time point, 4 hr after injury.  Representative images illustrate three 
time points to indicate the increases in the number of CD56+ SC (F and I vs C) 
(Figure 3.12).   
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Figure 3.12:  CD56 expression (green, FITC) in muscle sections taken at (B) 14 
days after placebo treatment in the control group, (E) 4 hr post-injury in the injured 
leg of the GSE group and (H) 3 d post-injury of the placebo group.  The photos on 
the right hand side (C, F, I) correspond to the time points of the photos in the middle, 
representing merged images of CD56 expression and that of Hoechst (blue) that 
stains nuclei (original magnification x 40).  PBS controls are presented in photos A, 
D and G.  CD56+ satellite cells are indicated by the yellow arrows.  White arrows 
indicate non-satellite cells.  Scale bar represents 10 µm.  Borderzone images of 
injury were captured and analysed. 
 
 
 
B CA
E FD
H IG
C-P 14 d
I-GSE 4 hr 
I-P 3 d
Stellenbosch University  http://scholar.sun.ac.za 
 90
3.5.3  M-cadherin 
M-cadherin+ SC numbers, expressed per myofibre are presented in Figure 3.13.  
There was a main effect of time and treatment (p < 0.001).  Four hr after the 
contusion injury, both the GSE and placebo group had significantly higher M-
cadherin expression, compared to their respective controls (p < 0.001 for both), 
whereafter the number of M-cadherin+ SC gradually decreased, until day 14.         
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Figure 3.13:  M-cadherin+ satellite cells expressed per myofibre number (M-
cadherin+ SC/myofibre number) (means  SD) at control levels (non-injured) and at 4 
hr, day 3, 7 and 14 post-injury.  Statistical analysis: Factorial analysis of variance 
with Bonferonni post hoc test (* p<0.05, *** p<0.001). n = 4 rats per time point per 
group. 
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Figure 3.14:  M-cadherin+ satellite cells visualised in the right gastrocnemius muscle 
by Texas red (B) 14 days after placebo treatment in the control group, (E) 4 hr post-
injury in the GSE group and (H) 4 hr post-injury in the placebo group.  Figures C, F 
and I represent merged images of the Figures in B, E and H, stained with both Texas 
red and Hoechst (original magnification x 40).  PBS controls are presented in photos 
A, D and G.  CD56+ satellite cells are indicated by the yellow arrows.  White arrows 
indicate non-satellite cells, whilst yellow arrows indicated satellite cells positive for M-
cadherin.  Scale bar represents 10 µm. Borderzone images were captured and 
analysed for the injured muscle. 
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Significant differences in M-cadherin expression were noted at 4 hr (p < 0.001) and 
on day 3 (p < 0.05) post-injury between the two treatment groups.  For this particular 
marker, the placebo group had higher values at both those time points.  
Representative images illustrating M-cadherin expression 4 hr after injury of both the 
GSE and placebo groups are presented in Figure 3.14.   
 
 
3.6  Foetal myosin heavy chain (MHCf) 
Figure 3.15 indicated the percentage of MHCf+ myofibres, with central nuclei.  A time 
effect was seen in both the GSE- and placebo-treated groups (p < 0.001).   
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Figure 3.15:  Foetal myosin heavy chain (MHCf) positive myofibres expressed 
relative to myofibre number (% MHCf+ myofibres) at control levels  and at 4 hr, day 3, 
7 and 14 post-injury (* p<0.05, *** p<0.001).  Statistics:  Factorial analysis of 
variance with Bonferonni post hoc test.  n = 4 rats per time point per group. 
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Figure 3.16:  Foetal myosin heavy chain expression is illustrated in Panels B,C, E 
and F.  Panels B and C represent a muscle section of a GSE supplemented rat 3 
days post-injury, whereas Panels E and F represent a muscle section of a placebo 
supplemented rat, 7 days post-injury.  FITC (green) was used to visualise the 
antibody and Hoechst (blue) was used as a nuclear marker.  Panels A and D 
represent PBS controls.  The yellow circles in Panels A and C represent the fibres 
positive for MHCf, however, only the muscle fibres in Panels B and D are truly 
regarded as being MHCf+, due to the presence of central nuclei.  Scale bar 
represents 10 µm.  Borderzone images of the injured muscle were captured and 
analysed. 
 
 
 
Following the contusion injury, the placebo group had a significant increase in the 
number of MHCf+ myofibres by day 3 after injury (p < 0.05), while reaching peak 
values by day 7.  However, by day 14, the MHCf content of the placebo group had 
significantly decreased compared to day 7 (p < 0.001).  A significant increase in 
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MHCf+ myofibres in the GSE group were already apparent 4 hr after injury compared 
to its respective control (p < 0.001).  A further increase in the percentage of MHCf+ 
myofibres was seen by day 3, after which the MHCf content of the GSE group 
decreased.  There was also a main effect of treatment, at 4 hr and day 3 after injury 
(higher in GSE vs placebo), and by day 7 (lower in GSE vs placebo).  
Representative images illustrating the increased number of MHCf+ fibres found by 
day 3 in the GSE group and day 7 in the placebo group are presented in Figure 3.16. 
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CHAPTER 4:  DISCUSSION 
 
 
 
To our knowledge, this is the first study to investigate the effect of supplementation 
with a natural plant product possessing antioxidant properties on skeletal muscle 
following a contusion injury.  Specifically, this is the first study investigating 
Oxiprovin™ administration daily to rats over a 2 to 4 week period to determine 
ORAC status and skeletal muscle SC activity following a contusion injury.  
 
 
4.1  Body mass 
Rats in all four experimental groups gained approximately the same amount of 
weight every day, irrespective of treatment.  However, rats belonging to the C-P 
group had a steeper growth slope when regression analysis was performed.  This 
steeper slope of the C-P group can be ascribed to the initial slightly lower body mass 
of the rats (not significantly different), which could influence the metabolic rate of the 
animals in that particular group.  Also, rats belonging to the injury groups lost weight 
directly after injury (i.e. 4 hr after injury), possibly due to the anaesthetics used and 
the amount of time it took for them to wake up after the procedure.  This weight loss 
was recovered 24 hr post-injury and no further differences were seen between the 
two treatment groups.   
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4.2  Creatine kinase 
As mentioned in Chapter 1, skeletal muscle contusion injury causes damage to the 
underlying muscle and plasma CK activity is often used as an indicator of the 
presence of muscle damage in humans [243-245] and animals [152, 246, 247].  
However, CK activity does not correlate proportionately to the extent of muscle 
damage, but rather that an association between elevated plasma CK activity and 
damage exist [152, 243-247].   
 
In a study by Akimau et al. (2005), the hind limb of rats was compressed for 6 hr with 
a weight of 3 kg [152].  Results indicated normal CK activity in animals receiving 
sham injury (placebo group) as 146 ± 100 U/L.  The results presented for the control 
groups in this thesis were just as widely spread and variable as the results obtained 
by Akimau et al. (2005).  The CK activity in the control placebo group was 214 ± 27 
U/L, whereas that in the control GSE group was 294 ± 71 U/L (see Figure 3.4).  In 
their study, the CK activity results in the placebo group stayed the same irrespective 
of injury.  However, after the hind limb was allowed to be reperfused for 3 hr 
following the compression in their study, the serum CK activity increased significantly 
(2641 ± 1683 U/L vs control values, p < 0.05).   
 
In contrast, in the current study, 4 hr after injury, CK activity only tended to increase 
(non-significantly), after which the CK activity gradually decreased again.  In the 
placebo group, the 4 hr and 3 d CK activities were still very similar, indicating a slow 
clearance of CK out of the muscle into the blood.  Moreover, even though the GSE 
group displayed significant differences over time with a greater CK peak 4 hr after 
injury, the placebo group had a 56 % larger CK activity AUC.  This can be explained 
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by significantly lower CK activities in the GSE group, seen already by day 3 after 
injury compared to 4 hr (p < 0.05), indicating on the one hand that the GSE 
supplement was associated with a quicker clearance of CK into the blood (4 hr), but 
also less sustained loss of CK by day 3 from the muscle due to less membrane/ECM 
damage.   
Two possible mechanistic explanations for the higher CK activity seen at 4 hr in the 
GSE group, as well as two possible mechanistic explanations for the decrease by 
day 3 after injury in the same group are presented below:  
i) GSE supplementation may have resulted in a more rapid increase in the 
inflammatory response.  This in turn would result in more immune cells infiltrating the 
damaged tissue, which could lead to secondary damage.  This explanation is 
possible, as it is known that GSE supplementation results in improved blood 
circulation [248].   
ii) Alternatively, improved circulation may simply have effectively cleared the leaking 
creatine kinase enzymes from the injured muscle bed to the systemic circulation.  
Proanthocyanidin, the active component of GSE, binds to collagen, strengthening 
the vasculature, especially capillaries [249].  Therefore, GSE may have reduced the 
damage done to the vasculature.   
iii) It is possible that a similar mechanism acting on muscle extracellular matrix 
resulted in lower CK release by day 3.   
iv) Furthermore, the decrease seen by day 3 may also be due to an improved and 
more rapid phagocytic process, as a result of better supply of neutrophils and 
monocytes to the site of injury.  A study by Loike et al. (1984) demonstrated that  
increased phagocytosis is positive correlated with a decrease in CK activity, 
supporting this abovementioned assumption [250].   
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A limitation of the current study with regard to the response of CK activity to injury is 
that its activity was not measured at more time points, allowing a better 
understanding of the time course of events following an injury.  Furthermore, muscle 
damage assessed in this way by means of CK activity is an indirect way of 
measuring skeletal muscle damage, because it measures circulating CK activity in 
the plasma/serum and not the actual amount of damage done to the muscle itself.   
 
 
4.3  Histology   
Previous studies on skeletal muscle contusion injury have focused on ultrastructural 
changes in the muscle during the recovery from a contusion injury [6, 156, 157].  
Histological staining with haematoxylin and eosin was also used in the current study, 
as well as in the studies mentioned above, to illustrate the extent of damage to the 
muscle following a contusion injury.  Similar time points were used in the current 
study to allow comparisons of muscle fibre ultrastructure to the other studies 
mentioned.  
 
Fisher et al. (1990) investigated the ultrastructure of skeletal muscle 6 hr after injury, 
as well as at various other time points after injury [156].  Since this 6 hr time point 
was the earliest time point available in the literature, the results obtained will be 
compared to our earliest time point of 4 hr.  At 6 hr in the injured muscle, a variable 
pattern of tearing and disruption of normal muscle fibre ultrastructure and small 
blood vessels was apparent.  Due to this local disruption of capillaries and small 
blood vessels, cellular constituents of the blood including erythrocytes and 
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neutrophils escaped into the intercellular space [156].  This qualitative observation 
was also evident in our study at 4 hr after injury independent of treatment.   
 
At 3 days after injury, the degree of vascular damage evident was reduced (also 
seen in the studies by Beiner et al. (1999) [6] and Kami et al. (1993) [157]), possibly 
as a result of either the large number of immune cells that had infiltrated the injured 
area resolving the damage or a rapid time course of vascular healing.  In the study 
by Kami et al. (1993), 2 days after injury, fibronectin (an extracellular matrix 
component responsible for modulating the activity of VEGF and angiogenic factor 
[251]) was observed filling the widened endomysium, indicating that the vasculature 
had started to heal [157].   
 
By day 7, the muscle at the site of trauma appeared to have regenerated to a 
significant extent compared to 4 hr and day 3 after injury.  At this time point of 7 
days, muscle fibres displayed multiple subsarcolemmal and central nuclei, indicating 
that the muscle fibres were in the process of regenerating themselves.  Central 
nucleation has long been recognised as a crucial feature of the regenerating process 
[252].  These results are also comparable to the results obtained by Beiner et al. 
(day 7), Fisher et al. (day 6) and Kami et al. (day 8) [6, 156, 157].  Fourteen days 
after injury, our GSE and placebo groups had relatively normal muscle ultrastructure, 
similar to results obtained by Beiner et al. (1999) [6] and Fisher et al. (1990) [156].  
However, in the placebo group, a few immune cells were still visible, indicating that 
the muscle had not healed completely compared to the GSE group.  Also, a 
qualitative assessment indicates that the intercellular space was still enlarged only in 
the placebo group.  Future studies should investigate whether fibronectin and VEGF 
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responses in the post-injury phase are modulated by GSE supplementation (or other 
antioxidant treatments) and whether this particular supplement may be involved in 
accelerating the vascular healing process after injury.   
Focussing on the muscle cells themselves, the qualitative results/data obtained for 
the GSE groups were similar to that of the placebo group at 4 hr after injury.  
However, by day 3, in the GSE group, more new muscle fibres were evident which 
could be compared to day 7 of the placebo group, suggesting that the GSE 
supplement accelerated the recovery process after injury by allowing earlier skeletal 
muscle fibre formation and therefore a quicker return of normal skeletal muscle fibre 
ultrastructure.  
 
Of the three studies mentioned above, only Beiner et al. (1999) investigated the 
effect of an intervention on the outcome of the muscle ultrastructure following a 
contusion injury [6].  In that study, the effect of anabolic steroids and corticosteroids 
on the healing of skeletal muscle after a contusion injury was investigated.  The 
results indicated that in an animal model corticosteroids may be beneficial in the 
short term, but they cause irreversible damage to healing muscle in the long term, 
including disordered fiber structure and a marked diminution in force-generating 
capacity.  Anabolic steroids may aid in the healing of muscle contusion injury to 
speed up the recovery of force-generating capacity, however, the use of anabolic 
steroids did not seem to accelerate new fibre formation as was apparent after 
Oxiprovin™ supplementation.  Future studies using the GSE supplement should also 
investigate the time couse of recovery of force-generating capacity of the muscle 
following a contusion injury. 
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4.4  ORAC assay  
The ORAC assay measures the total amount of antioxidants present in an aqueous 
system, therefore we do not know what the exact contribution of the lipophilic 
antioxidants is.  However, because the GSE supplement we used in our study was 
dissolved in 0.9% saline, an aqueous solution, the ORAC assay was considered to 
be the best available method to determine the oxygen radical scavenging capacity. 
 
Mazza et al. (2002) investigated the consumption of proanthocyanidins by humans 
and its effect on the serum antioxidant status was assessed by the ORAC assay 
[253].    In this particular study, it was found that there was a 1.16 fold increase in 
ORAC in the proanthocyanidin group already apparent 4 hr after consumption 
compared to the placebo group.  However, this increase was not statistically 
significant, although a tendency towards significance was reported (p < 0.06).  In the 
current study, there was a significant difference in plasma ORAC between the 
placebo and the GSE group, 2 weeks after treatment (p < 0.05).  It can therefore be 
concluded that although 4 hr after proanthocyanidin consumption, a difference is 
apparent between the two treatment groups as seen in the study by Mazza et al. 
(2002), a longer timeframe is needed for the proanthocyandins to reach a peak value 
and to remain stablely elevated.  In the current study, ORAC was also measured in 
the muscle.  Just as in the plasma, the ORAC results indicated a significant 
difference between the placebo and GSE control groups (1.25 fold increase).  This 
significantly higher ORAC value of the GSE group therefore indicates that the 
antioxidants present in the GSE (proanthocyanidins – a compound of the flavonoid 
family), provided a better free radical scavenging ability, than is normally present in 
the placebo group.   
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Few statistically significant differences in plasma ORAC were apparent over time in 
response to injury.  Although no statistically significant differences were seen 
between any time points in the placebo group’s plasma ORAC, the GSE group had a 
significant decrease in ORAC 4 hr after injury.  This is possibly due to the generation 
of reactive species by circulating macrophages and neutrophils, and antioxidants 
themselves (as described in the literature), which neutralised a significant amount of 
the available antioxidant capacity.  Although reactive species lead to secondary 
damage [91, 92, 254], no literature is available on the possible connection between 
GSE and secondary damage.  The decrease in ORAC seen at 4 hr is in accordance 
with the increase seen in CK activity at 4 hr in the GSE group.  Together these data 
indicated an enhanced early response to injury.  Three days after injury, the ORAC 
of the GSE group was similar to the GSE pre-injury control values.  At this time point, 
there was a significant difference between the two treatment groups, indicating on 
the one hand that more radical species were still being generated in the placebo 
group, and on the other hand the GSE group had regained its radical quenching 
ability.    
 
In contrast to the lack of significant change in plasma ORAC, muscle ORAC was 
significantly increased by day 7 after injury in the placebo group.  There are several 
possible explanations for this result:   
i) More cytosolic proteins may leak into the muscle after injury including antioxidant 
and reactive species neutralizing proteins [254].   
ii) Reactive species generating compounds may not be present to the same extent in 
the newly generated muscle fibres, hence the inherent quenching ability is not 
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required as much and the net effect is elevated muscle ORAC.  Possible candidates 
include amongst other things iron or iron-containing proteins like myoglobin [254].    
iii) Thirdly, although no studies are available on this particular aspect, I speculate 
that the composition of the regenerating proteins present in the muscle could also 
have changed, offering better reactive species buffering/antioxidant quenching 
capacity.   
 
From day 7 to day 14 after injury in the placebo group, there was a significant 
decrease in muscle ORAC, probably as a result of increased protein expression and 
protein turnover, as seen in a study by Gierer et al. (2003) regarding myosin heavy 
chain expression in denervated muscle [255].   In addition to the proteins present in 
the muscle, SC might also play an essential role, because it is known that reactive 
species are generated upon SC activation, proliferation and fusion [16], indicating a 
possible role for SC in ORAC decrease in inflamed regenerating muscle.  Therefore, 
SC by day 7 in the placebo group could comprise a greater proportion of the 
cytoplasmic to nuclear content of the muscle after injury indicating that SC might be 
busy proliferating and fusing.  This explanation is most probably the main reason, as 
seen in our SC data (see figure 3.11), where a decreased number of CD56+ SC were 
observed by day 7 and 14 in the placebo group.  In turn, this could mean that more 
processes might occur in these nuclei, which could produce reactive species.   
 
The GSE group had a significant decrease in muscle ORAC 4 hr following injury 
compared to the control GSE group.  Four hours after injury, the disrupted 
vasculature may have caused a rapid loss of antioxidant delivery to the site of injury 
or the immune and satellite cells generated more ROS which needed to be 
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quenched.  In addition, one could postulate that the change in ORAC is the result of 
inflammation and could therefore be the influence of neutrophils and macrophages.  
As it is known that neutrophils (activated very early after injury  – as early as 4 hr) 
and macrophages are responsible for reactive species generation as part of the 
inflammatory process [89-92], it might possibly explain the events following a 
contusion injury.  As part of the phagocytic process, neutrophils produce substantial 
amounts of ROS [254, 256], which play an essential role in the regeneration of 
tissue, by activating more neutrophils to remove damaged proteins [254].  Although 
Child et al. (1999) reported that inflammation did not alter the antioxidant status after 
multiple bouts of eccentric exercise over 12 days [257], a possible influence of 
inflammation on ORAC (total antioxidant capacity – TAC used in their study) may be 
an early response (as early as 4 hr as seen in our study), when CK was elevated 
after eccentric exercise.  However, TAC was not investigated at earlier time points 
prior to 4 days, therefore the possibility that their biopsy sampling missed the peak in 
neutrophil-mediated oxidative stress cannot be discounted.  Furthermore, although 
this conclusion regarding antioxidant status and inflammation was drawn, the study 
design also included the multiple bouts of exercise to which muscle could have 
adapted the endogenous antioxidant capacity, therefore masking the effect of an 
inflammation on ORAC.  In the current study however, only a single contusion injury 
was applied to the muscle, therefore, inflammation may have caused the changes in 
ORAC seen over time.       
 
The muscle’s cellular integrity recovered rapidly by day 3 as indicated by H&E.  At 
this time point, the GSE group had a significantly higher ORAC than the placebo 
group, indicating that the chronic antioxidant supply in the GSE group was once 
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again delivered to the muscle.  Alternatively, adaptation of antioxidant enzymes in rat 
skeletal muscle may have occurred in response to the chronic GSE supplementation 
by further increasing the number of enzymes present.  Similar findings were seen in 
an exercise study, where it was found that chronic vitamin E supplementation may 
influence the adaptation of glutathione peroxidase (GPX) and superoxide dismutase 
(SOD) activities in rat skeletal muscle  [258].  By day 14, the ORAC in both treatment 
groups returned to control values, indicating that the muscle had recovered and that 
the differences seen in ORAC here were due to supplementation only.   
 
 
4.4  Satellite cells 
Various articles report on the expression of different SC markers during recovery 
from exercise (e.g. strength training, eccentric exercise or stimulation) [122, 144, 
259], and these studies have been performed in humans, animals and cell culture 
models.  However, limited data are available on SC marker expression after 
sustaining a contusion injury, and the change in expression during the recovery 
process [260].  Moreover, research has focused on ultrastructural events following 
injury and no data has been presented on Oxiprovin™ or other proanthocyanidin 
products and possible effects on SC expression following a contusion injury.  
Controversies also exist in the literature on specific SC markers and when exactly 
they are expressed [15, 123, 125, 140, 141, 144].  For the purpose of this study, the 
following conclusions were drawn regarding the SC markers used and their 
expression pattern: CD34 can be used as a marker of quiescence and early 
activation (taking into account position), CD56 can be used as a marker of SC in 
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either quiescence, activation or proliferation phases and similarly M-cadherin can be 
a marker of either quiescence, activation or proliferation.     
 
4.4.1  CD34 
We showed time and treatment effects on CD34 expression in vivo at almost all time 
points.  In our study, no significant difference in CD34 expression was evident 
between the two pre-injury control groups, but a biphasic response to injury was 
apparent in both treatment groups.  Four hr after injury, the placebo group displayed 
a significant increase in the number of CD34+ SC, which may be due to the 
activation and migration of SC from another area into the injured area still carrying 
“the quiescent marker” (CD34).  Another explanation might be that newly activated 
SC still expressed the “quiescent marker”, even though they may also express an 
activation marker.  This is quite possible, as CD34 labels both quiescent and early 
activated SC [123, 140].  Migration and activation, according to Hirata et al. (2003), 
occur simultaneously [261], therefore both of the abovementioned explanations may 
be true.    
 
In the placebo group, 7 days after injury, there was an even more significant 
increase in CD34 expression than that seen at 4 hr and day 3 after injury.  During 
this time SC would be proliferating but may also be returning to quiescence after 
fusion has taken place, although the return of a SC to quiescence hasn’t been as 
intensely studied as SC activation.  In a study by Allen et al. (2005), SC from 9-
month-old adult rats (quiescent in vivo) were isolated and cultured [262].  These 
quiescent SC displayed a lag phase prior to division and under normal growth 
conditions, divided for the first time between 42 and 60 hr.  However, in the presence 
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of HGF, SC proliferated sooner.  Therefore it is logical that the increased expression 
of CD34 by SC by day 3 indicates proliferation of SC.  Fourteen days after injury 
however, the CD34 levels in the placebo group had returned to control values 
indicating that the SC had fused.   
 
The GSE group had a similar CD34 pattern to the placebo group, although the 
increase in the number of CD34+ SC occurred earlier in the GSE group (already at 4 
hr following injury) compared to the placebo group.  Since at this early time point 
proliferation cannot be an explanation, this indicated that the GSE group had a better 
migration of immune cells into the injured area, as a result of improved blood flow to 
the site of injury [248], sufficient to secrete the cytokines required to attract the SC 
for regeneration.  Another explanation for this earlier increase in CD34 expressing 
cells may also be that migration is present at this time, but not fusion.  A possible 
mechanism is a better suppression of cell surface or chemoattractive proteins 
(chemokines) in the GSE group.  A study by Roebuck et al. (1999) illustrated that 
antioxidants inhibited the TNF-α mediated stimulation of chemokine expression 
[263], indicating that the suggestion made here is quite valid.  By day 14, the GSE 
group had similar CD34+ SC numbers than that of controls. 
 
In contrast to CD34, CD56 has been used more frequently to assess SC in human 
and mice muscle biopsies, mainly making use of the vastus lateralis and 
gastrocnemius muscle [143, 144, 259, 260].  However, CD56 stains both quiescent 
and activated SC and no distinction between the quiescent and activated SC pool 
has been attempted in any of these studies.  A possible way in which to distinguish 
between these two SC pools will in the end be to use a combination of markers of 
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quiescence, in particular Pax7 [124] and CD34 [123], or activation, particularly M-cad 
and CD56 [122], or Pax3 [17] and CD56 [122].  Pax7 is probably the most useful 
current marker for identifying quiescent satellite cells [124], whereas Pax3 is also 
now accepted as a good marker for activation and proliferation [17]. 
 
4.4.2  CD56  
In the current study, similar results were obtained when staining muscle sections 
with CD56 compared with CD34, possibly indicating co-expression of CD34 and 
CD56 during the quiescent and early activation stages of SC during recovery.  
However, more SC expressed CD56 than CD34 in the GSE group 4 hr after injury 
and by day 3 after injury.  Resolution also followed a relatively similar pattern to that 
seen for CD34.  CD56 peaked in the placebo group 3 days after injury and stayed 
elevated until day 7.  This increase in CD56 may indicate that SC are starting to 
proliferate, however, co-staining with other markers of proliferation, 
bromodeoxyuridine (5-bromo-2-deoxyuridine, BrdU) and proliferating cell nuclear 
antigen (PCNA) are needed to try and verify whether this is true [17, 24].  These 
markers are generally regarded as true markers of proliferation, as opposed to other 
markers which labels quiescent, activated and proliferating SC [17, 24].   
 
Nitric oxide, expressed by activated macrophages [93], has been suggested as one 
of the activators of SC [115] and may be involved in inducing CD56 expression.  
However, CD56 has also been shown to be diffusely distributed in denervated 
human skeletal muscle, whereas there was no expression of the sarcolemma-
associated nitric oxide synthase (NOS I) [264].  As the muscle started to heal and an 
increase in the number of re-innervated muscle fibres was apparent, the intensity of 
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CD56 expression decreased progressively, whereas that of NOS I increased.  Thus, 
changes in CD56 expression after injury, as seen here, may indicate a change in 
neural stimulation or release of neural factors during the injury.  For future studies, it 
might be useful to determine the exact time course of re-innervation, as well as to 
investigate the interaction between CD56 and other neural factors known to be 
expressed during re-innervation.      
 
Fourteen days after injury, there was a significant decrease in CD56 expression in 
the placebo group, again similar to the data obtained for CD34.  In an in vitro study it 
was shown that CD56 expression enhances fusion of myoblasts to form myotubes 
[265], thus suggesting that CD56 has a role in myoblast fusion.  Therefore, the 
decrease in CD56 expression seen 14 days after injury could indicate that the SC 
have fused, as the number of SC were similar to the placebo control.   
 
CD56 also followed a similar pattern to CD34 in the GSE group.  Four hr after injury, 
there was an increase in CD56 expression, after which the number of CD56+ SC 
gradually decreased.  During this time point, a significant difference was seen 
between the two supplementation groups, providing evidence that SC are activated 
earlier after injury in the presence of Oxiprovin™.  By day 14, all SC levels were 
similar to control values, indicating that the repair phase had reached completion.   
 
4.4.3  M-cadherin 
Pre-injury, no difference in M-cadherin (M-cad) expression was seen in the control 
groups.  However in comparison to CD34 and 56, almost double the number of SC 
were identified using this marker.  A possible explanation for the higher number of 
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SC seen when labelling muscle sections with M-cad could be due to the normal 
calcium-potassium balance or the release of calcium (Ca2+) from the sarcoplasmic 
reticulum (SR) [266].  During contraction, calcium enters the muscle cytoplasm, while 
potassium leaves the cells, therefore there will always be calcium present inside and 
outside the muscle cells, even at rest, thus M-cad will always be expressed.  
Although it is known that M-cadherin is a calcium-dependent adhesion molecule 
[128, 130], it is not known how the interaction between M-cadherin and Ca2+ causes 
M-cadherin to be expressed on the outside of the muscle beneath the basement 
membrane.   
 
Four hr after injury, there was a significant increase in the number of M-cad+ SC in 
the placebo group to levels similar to the CD56+ SC in the GSE group.  Thereafter 
the number of M-cad+ SC gradually decreased from day 3 until day 14.  In a study by 
Ozawa et al. (1990), removal of Ca2+ ions, usually required for cadherin-mediated 
adhesiveness, mimicked the inhibitory effect of the M-cad peptide 040/M [267], and a 
decreased M-cad expression should be expected.  Conversely, immediately 
following a contusion injury (within 15 min), the calcium-potassium balance inside the 
muscle cell is disrupted and the SR membranes leak more Ca2+ ions, causing the 
build-up of Ca2+ inside the muscle cell.  The rate at which Ca2+ accumulates inside 
the cell, is far greater than the rate at which the potassium inside the cell is able to 
difuse to the outside, causing a negative shift in the electrical potential [268].   
Therefore, due to the fact that M-cad is a calcium dependent adhesion molecule 
[128, 130], an increase in Ca2+ would therefore cause an increase in M-cad adhesion 
to the muscle membrane, as seen with an increase in M-cad expression at 4 hr after 
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injury in the placebo group.  Therefore, it is plausible that the increase in M-cad at 4 
hr after injury is the result of increased Ca2+ influx to the site of injury.   
 
Furthermore, the gradual decrease in M-cad expression seen by day 3 in the current 
study can also be ascribed to the change in the Ca2+ balance in the muscle, as the 
recovery of the Ca2+ balance ([Ca2+] returning to normal) in the muscle would 
therefore cause a decrease in the number of M-cad+ SC.  In the study by Leybaert 
and De Ley (1994) already mentioned [268], the interstitial ionic changes were 
completely reversible within 90 min following injury, however their study made use of 
a cat model with a less severe injury when compared to the rat model of contusion 
injury used in the current study.  Therefore it is possible that in the current study, the 
time it took for the calcium balance to return to normal, took relatively longer.  It 
should also be noted that no other time points between 4 hr and day 3 were 
observed, in which the M-cad expression could also have shown a decrease prior to 
the decrease seen by day 3. 
  
Similarly, the GSE group also displayed an increase in M-cad expression directly 
after injury, followed by a gradual decrease.  However, the number of M-cad+ SC in 
the placebo group was significantly higher than that of the GSE group.  Due to the 
fact that proanthocyanidin comprise a group of polyphenolic bioflavonoids 
ubiquitously found in fruit and vegetables [201-203], it is likely that proanthocyanidins 
may interact with intracellular Ca2+ as well as with other components to elicit its 
protective effect.  A possible way in which proanthocyanidins can work, may include 
the interaction with Ca2+ ions, leading to a reduction in the ionized Ca2+ content 
inside the cell.  By this mechanism, proanthocyanidins may increase the binding 
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affinity of a substrate to improve the transfer of antioxidant enzymes to the injured 
muscle, thereby providing further protection against injury-induced calcium overload.  
However, this particular aspect of proanthocyanidins mechanism of action involving 
Ca2+ still merits research in order to clarify discussion.  A possible way of 
investigating the effect of proanthocyanidins on the Ca2+ balance would be to tag the 
Ca2+ ions with a fluorescent marker to visualise the changes in calcium balance 
immunohistochemically.      
 
 
4.5  Foetal myosin heavy chain (MHCf)  
The embryonic or foetal myosin heavy chain isoform is expressed predominantly in 
developing skeletal muscles, but can also be detected in the adult muscle in 
regenerating fibres, where central nuclei are apparent [242].  Therefore, it was 
assumed that MHCf+ staining in this study represents regenerating muscle fibres 
formed after sustaining the contusion injury.  However, due to the fact that the 
particular antibody used was a mouse-anti human antibody, it may not have been 
specific only to the MHCf isoform and regenerating myofibres, but may have labelled 
another MHC isofom in other fibres without central nuclei as well.  Although no 
articles are available on possible sequence homology between MHCf and other MHC 
isoforms, it is not certain which isoform is also stained positive with this particular 
marker.  However, for future studies, this problem can be overcome by co-staining 
with other adult MHC markers making use of immunohistochemistry, mATPase 
staining techniques can also be used, as well as Western blotting to possibly identify 
the other isoform.  This will then enable us to use this marker in other rat-based 
studies to determine the MHC content of a particular muscle sample.    
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In light of the above, in order to calculate the actual number of regenerating 
myofibres, counting of positively stained MHCf myofibres with central nuclei was 
needed. To our knowledge, this is the first time that the immunohistochemical 
expression of MHCf has been used in conjunction with a contusion injury.  However, 
this particular antibody was also used in a cryoinjury experiment to rat hearts, but no 
mention of central nuclei was made.  The data of the MHCf expression found in the 
current study supports the findings of CD56+ staining since the biggest differences 
were seen between the 2 groups in the early time points (4 hr and 3 d).  As it is 
known that CD56 is a marker of activation of satellite cells and possibly fusion into 
myotubes, it was expected that an increase in CD56 should be followed closely by 
an increase in MHCf.  In future, markers of fusion could possible be of use, however 
no markers of fusion for use in immunohistochemical staining or any in culture 
techniques exist. 
 
Both control groups showed no centrally nucleated fibres with MHCf expression.  The 
placebo group displayed an early increase in the number of MHCf+ myofibres by day 
3 after injury (compared to control), but reached a peak by day 7.  Similar qualitative 
histological findings of regenerating myofibres by day 6-8 were found in placebo 
controls in our study (section 3.3), as well as other studies [6, 156, 157].  However, 
in these studies immunohistochemistry was not used to quantitate the data obtained, 
but rather histological staining with haematoxylin and eosin was used.   By day 14 in 
the placebo group, the number of MHCf+ myofibres decreased again.  During this 
time point, it was noticed that some of the myofibres displayed central nuclei, without 
MHCf+ staining, thereby possibly indicating that these fibres had already matured, 
but that the nuclei had not migrated to the sub-sarcolemma region yet.  A possible 
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way to investigate the migration of nuclei, may be to inject BrdU to label the 
proliferating pool of SC in order to identify nuclei and possibly their migration to the 
sarcolemma.  However, no such studies have been attempted.       
 
The GSE group displayed a similar rise and then fall in MHCf+ staining compared to 
the placebo group.  However, the number of MHCf+ myofibres showed an earlier 
significant increase at 4 hr, which increased even further and peaked on day 3, 
whereafter, MHCf expression decreased.  Again here, these data illustrated GSE’s 
effect in accelerating the recovery process after injury, and was also validated by 
histological staining.  In the GSE group, the presence of myofibres with central nuclei 
(negative for MHCf), were also observed.  However, in this particular group this 
phenomenon was seen by day 7 already.       
 
 
4.6  Summary and conclusion 
A contusion injury is the leading cause of discomfort in athletes participating in high 
contact sports, such as rugby and soccer today, and although several therapeutic 
strategies have been developed to treat the symptoms of such an injury, few of them 
have been successful.  Through the use of an in vivo model of skeletal muscle 
contusion injury, we were able to mimick a contusion injury in rats.  This enabled us 
to successfully determine the severity of injury, firstly by investigating its effect on 
skeletal muscle fibre ultrastructure and the inflammatory response (haematoxylin 
and eosin) and secondly by investigating qualitatively its effect on the vascular 
system (CD31).  Although both treatment groups showed a similar pattern of 
damage to the skeletal muscle fibre ultrastructure and the vasculature, followed by a 
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rapid immune cell infiltrate in the injured area, the GSE-supplemented group showed 
a much better and quicker recovery time following the contusion injury.  This is the 
first study, which has shown quicker recovery from such an injury through the use of 
antioxidant supplements (Oxiprovin™) in a rat model.  ORAC results indicated that 
groups supplemented with GSE had a better free radical scavenging effect, and in 
conjunction with the lower plasma CK activities found in the GSE group, it was 
concluded that GSE supplementation could protect the skeletal muscle against 
secondary damage.   
 
Labelling muscle sections with different SC markers enabled us a better 
understanding of the involvement of SC in the recovery process following a 
contusion injury.  CD34 and CD56 showed quite similar expression patterns and 
both the two treatment groups had similar resolution patterns following injury except 
that the GSE group had an earlier elevation of SC compared to the placebo group.  
In light of the more specific results obtained in the current study, it can be concluded 
that CD34 labeled quiescent as well as early activated SC and that CD34+ SC 
migrated to the area of damage.  Furthermore, interpreting CD34 data was 
complicated by the fact that CD34 was not specific to all activated and quiescent SC, 
but only to a proportion of SC.  M-cadherin (calcium dependent), according to the 
literature is a similar marker to CD56 [121, 128], labelling activated, quiescent and 
proliferating SC, surprisingly showed completely different results than those for 
CD56.  In this study, the number of M-cadherin+ SC in the placebo group were 
higher at all time points following injury, indicating that GSE supplementation may 
have exerted its protective function by influencing calcium homeostasis during the 
recovery process.  The data therefore suggested that CD34 is a marker of a subset 
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of quiescent as well as activated SC, and that CD56 labels quiescent, activating and 
proliferating SC.  However, co-staining with other markers of quiescence and 
activation is needed.  Furthermore, care should be taken when interpreting data, as 
even a slight disruption in calcium homeostasis could influence the relationship 
between results obtained with M-cadherin and CD56.    
 
We can also conclude that supplementation with Oxiprovin™ (GSE) did in fact 
accelerate the healing process.  Activation of SC occurred quicker in the GSE-
supplemented group compared to the placebo group, as seen with CD34 and CD56 
staining.  Furthermore, muscle fibres showed regenerating capacity much quicker in 
the GSE group compared to the placebo group, as seen through histological staining 
with H&E, as well as labeling with MHCf.   
 
Although in the current study, Oxiprovin™ was successfully proven to be beneficial 
in treating contusion injuries, this study had a few limitations.  Firstly, the control 
uninjured groups were sacrificed 14 days earlier than the injured groups, allowing no 
direct time comparisons between groups. This omission was a planned one, to 
reduce the number of animals required for the study, to reduce the cost of the study, 
as well as due to the limited capacity of the small animal house.  Secondly, 
additional earlier time points prior to 7 days post-injury may potentially elucidate the 
exact timecourse of events following a contusion injury. The time points chosen were 
done after consultation of the literature, and were also limited for the same reasons 
stated above.   
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Since this is the first study to show an effect of Oxiprovin™ supplementation at 
tissue level in animals prior to and after sustaining a contusion injury, we cannot rule 
out the importance of investigating other parameters such as immune cells, which 
may also play an important role in further elucidating the results obtained.  
Furthermore, we cannot rule out the possibility that acute Oxiprovin™ 
supplementation in the post-injury period only, could also be beneficial.  The 
possibility of not only using OxiprovinTM as a preventative measure, but also as a 
complementary remedial treatment, is worth investigating further. In addition, a live 
cell culture model of injury, might also be useful in determining the effect of 
Oxiprovin™ as well as the exact time course of events following such an injury in 
vitro and therefore relating it to the in vivo conditions seen in the current study.  
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Appendix A:  ORAC assay 
 
Reagents 
Table presenting the reagents used for the ORAC assay 
Reagent 
 
[Stock]  [Working] Supplier 
AAPH*  153 mM  
0.414 g in 10 ml Phosphate buffer 
pH 7.4 
Sigma-Aldrich 
Fluorescein 
 
5x10-3 mM 8.16x10-5 mM  
Made up in phosphate buffer, pH 
7.4 
Sigma-Aldrich  
Potassium 
Phosphate buffer 
 75 mM (pH 7.4) 
6.5 g K2HPO4 in 500 ml dist. H2O 
5.1 g KH2PO4 in 500 ml dist. H2O 
Sigma-Aldrich 
Trolox** 
 
0.02 M 6.25 µM; 12.5 µM; 25 µM; 50 µM 
in phosphate buffer, pH 7.4 
 
Sigma-Aldrich 
 
*  2,2’-Azobis-(2-methylpropionamidine)-dihydrochloride 
**  6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
 
 
Method 
 
1. Defrost plasma samples at room temp and dilute them 75x with phosphate buffer. 
2. Add 150 l fluorescein working solution to each well of a black plate. 
3.  Add 25 l TROLOX standards or plasma in triplicate to respective wells. 
 
 BUFFER TROLOX PLASMA AAPH FLUORESCEIN
BLANK 25 l ----- -----  150 l 
STD ----- 25 l -----  150 l 
SAMPLE ----- ----- 25 l  150 l 
 
4.  Cover plate with lid and incubate in preheated reader (37oC) for 10 min with 3 min 
shaking. 
5.  Add 25 l AAPH rapidly to each well. 
6.  Read for 35 min with fluorescence measured every minute. (Excitation 
wavelength = 485  20 nm; emission wavelength = 530  25 nm). 
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Appendix B:  Bradford assay 
 
Reagents 
1.  200 µg/ml BSA (bovine serum albumin) stock solution – Sigma-Aldrich 
2.  Bradford reagent – Sigma-Aldrich 
 
Method 
1.  Generating the BSA standard curve: 
[ ] µg/ml BSA stock Distilled water Bradford reagent 
20 100 µl 0 µl 900 µl 
16 80 µl 20 µl 900 µl 
12 60 µl 40 µl 900 µl 
8 40 µl 60 µl 900 µl 
4 20 µl 80 µl 900 µl 
2 10 µl 90 µl 900 µl 
0 0 µl 100 µl 900 µl (BLANK) 
 
2.  Vortex and leave on ice for 5 min. 
3.  Zero the spectrophotometer with the BLANK and read the absorptions of the 
standards at 595 nm. 
4.  Prepare the samples – 5 µl of sample, 95 µl distilled water and 900 µl Bradford 
reagent.  Vortex and read the absorption at 595 nm (Note:  samples stable for up to 
1 hr after preparation). 
5.  Plot the standard curve and calculate the protein concentration in µg. 
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Appendix C:  Automatic tissue processing. 
 
Reagents 
1.  Alcohol (70 %, 90 %, 95 %, 100 %) 
2.  Xylene – Sigma-Aldrich 
3.  Paraffin wax – Merck, Histosec melting point 56 °C 
 
Method 
Processing time: 
 A)  Dehydration 
  1)   70 % alcohol    – 1.5 hr 
  2)   70 % alcohol    – 1.5 hr 
  3)   90 % alcohol    – 1.5 hr 
  4)   95 % alcohol    – 1.5 hr 
  5)   95 % alcohol    – 1.5 hr 
  6)   100 % alcohol  – 1.5 hr 
  7)   100 % alcohol  – 1.5 hr 
  8)   100 % alcohol  – 2.0 hr 
 B)  Clearing 
  9)    Xylene                – 1.5 hr 
  10)  Xylene                – 2.0 hr 
C)  Impregnation 
  11)  Paraffin wax   – 2.0 hr 
  12)  Paraffin wax   – 2.0 hr 
 Thus Total processing time = 20 hr 
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Appendix D:  H&E staining protocol  
 
Reagents 
1.  10 % Acid alcohol 
       10 ml 1 % HCl dissolved in 1 ℓ 70 % alcohol 
2.  Alcohol (70 %, 95 %, 100 %) 
3.  Eosin 
       Stock solution: 
10 g Eosin dissolved in 1 ℓ distilled water 
       Working solution: 
10 ml Eosin stock solution dissolved in 90 ml distilled water. 
Prepare fresh daily. 
       For staining:   
           Add 2 – 3 drops glacial acetic acid per 100 ml before use. 
4.  Haematoxylin 
       5 g Harris haematoxylin  
       100 g Ammonium Alum 
       50 ml 100 % alcohol 
       1 ℓ distilled water 
       2.5 g Mercuric oxide 
 
       To prepare:  Dissolve haematoxylin in alcohol. 
    Add Ammonium Alum to distilled water and heat to boiling point. 
                           Immediately add mercuric Oxide and shake until solution has   
                           purple-black colour. 
     Cool rapidly in fridge. 
 
       For staining:  Filter before use. 
                             Add 4 ml glacial acetic acid per 100 ml of haematoxylin. 
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5.  Scott’s tap water 
       3.5 g NaHCO3 
       20 g MgSO4 
       10 ml 37 % Formalin 
       1 ℓ tap water 
   
       To prepare:  Dissolve NaHCO3 in tap water first. 
                           Add MgSO4 and formalin. 
6.  Xylene 
 
Method 
1.  Xylene (10 min) 
2.  100 % alcohol (10 dips) 
3.  100 % alcohol (10 dips) 
4.  95 % alcohol (10 dips) 
5.  95 % alcohol (10 dips) 
6.  70 % alcohol (10 dips) 
7.  Rinse in distilled water 
8.  Haematoxylin (3 min) 
9.  Rinse in distilled water 
10.  Rinse in acid alcohol 
11.  Rinse in distilled water 
12.  Blue in Scott’s tap water 
13.  Rinse distilled water 
14.  2 min in Eosin 
15.  Rinse in distilled water 
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16.  70 % alcohol (10 dips) 
17.  95 % alcohol (10 dips) 
18.  95 % alcohol (10 dips)   
19.  100 % alcohol (10 dips) 
20.  100 % alcohol (10 dips) 
21.  Xylene (10 dips) 
22.  Xylene (10 dips) 
23.  Mount with coverslip 
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Appendix E:  Conventional deparaffinization and dehydration sequence of 
paraffin embedded tissue prior to immunohistochemistry. 
 
Reagents 
1.  Alcohol (50 %, 80 %, 95 %, 100 %) 
2.  Xylene – Sigma-Aldrich 
3.  0.1 % Trypsin – Highveld 
         0.1 g trypsin in 100 ml PBS  
 
Method 
1.  Incubate sections in Xylene: 2 changes, 5 min each 
2.  100 % absolute alcohol:  2 changes, 3 min each 
3.  95 % alcohol:  2 changes, 3 min each 
4.  80 % alcohol:  3 min 
5:  50 % alcohol:  3 min 
6.  Rinse in distilled water:  2 changes, 3 min each 
7.  Place slides in prewarmed (37 °C) 0.1 % trypsin for 20 min 
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Appendix F:  Immunohistochemistry staining procedure (2 markers) 
 
Reagents 
1.  PBS, pH 7.4 
       1 ℓ of 1 M phosphate buffer, 90 g NaCl, 9 ℓ ddH2O  
2.  Donkey serum – Jackson Immunoresearch Inc. 
3.  For antibodies used, see Chapter 2, section 2.3.4 for reagents 
 
Method 
1.  Wash slides in PBS after trypsin (step 7, Appendix E). 
2.  Encircle samples with a wax pen. 
3.  Block for 20 min in 5% serum at room temperature (RT). (Note: use the same serum 
in which the secondary antibody is raised) 
4.  Shake off serum and incubate sections for 4 hr at RT with the 1st primary 
antibody.  (Note:  Do not wash after serum blocking step) 
5.  Wash slides with PBS and add the secondary antibody (1/1000 for anti-mouse) to 
the sections.  Incubate for 40 min at RT. 
6.  Wash slides and incubate slides with 1/500 FITC for 30 min at RT. 
7. Wash slides with PBS and add the 2nd primary antibody overnight at 4°C. 
8.  Add the secondary antibody (1/1200 for anti-rabbit) for 40 min after washing the 
sections thoroughly with PBS. 
9.  Wash sections and add 1/500 Texas Red tertiary antibody for 30 min at RT. 
10.  Add Hoechst (1/200) for 15 min to the Texas red. 
11.  Wash slides well and mount with DAKO fluorescent mounting medium. 
(Note:  if only use 1 antibody, apply steps 1-6 and then 10 and 11) 
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Appendix G:  Results of figures in Chapter 3 indicated as mean ± SD 
 
Figure 3.2:  Difference in growth over time 
 
Group Slope Upper limit Lower limit 
I-P 4.69 4.38 5.00 
I-GSE 4.81 4.44 5.19 
C-P 6.89 6.33 7.45 
C-GSE 5.24 4.90 5.58 
 
 
Figure 3.3:  Total plasma creatine kinase (CK) activity expressed as units/liter (u/ℓ) 
 
Time point Placebo GSE 
Control (non-injured) 214 ± 27.1  294 ± 71.3  
4 hr (post injury) 354 ± 162  557 ± 216  
Day 3 (post injury) 339 ± 145  221 ± 46.1  
Day 7 (post injury) 243 ± 108  218 ± 92.4  
Day 14 (post injury) 271 ± 168  214 ± 57.0  
 
 
Figure 3.7:  Plasma oxygen radical absorbance capacity expressed as µmol Trolox 
equiv/ℓ 
 
Time point Placebo GSE 
Control (non-injured) 3045 ± 26.4  3152 ± 31.3 
4 hr (post injury) 3016 ± 137 2980 ± 172  
Day 3 (post injury) 2981 ± 98.4 3140 ± 28.6 
Day 7 (post injury) 3100 ± 77.1 3078 ± 124 
Day 14 (post injury) 3089 ± 38.0 3029 ± 30.0 
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Figure 3.8:  Muscle oxygen radical absorbance capacity expressed as µmol Trolox 
equiv/µg protein 
 
Time point Placebo GSE 
Control (non-injured) 466 ± 32.0 583 ± 39.6  
4 hr (post injury) 474 ± 48.9 487 ± 37.6 
Day 3 (post injury) 500 ± 52.0 607 ± 46.2 
Day 7 (post injury) 648 ± 21.1 586 ± 35.5 
Day 14 (post injury) 473 ± 35.7 573 ± 46.4 
 
 
Figure 3.9:  The number of CD34+ satellite cells/myofibre 
 
Time point Placebo GSE 
Control (non-injured) 0.026 ± 0.004 0.026 ± 0.005 
4 hr (post injury) 0.074 ± 0.004 0.140 ± 0.025  
Day 3 (post injury) 0.054 ± 0.007 0.073 ± 0.019 
Day 7 (post injury) 0.121 ± 0.009 0.072 ± 0.015 
Day 14 (post injury) 0.025 ± 0.003 0.029 ± 0.011 
 
 
Figure 3.11:  The number of CD56+ satellite cells/myofibre 
 
Time point Placebo GSE 
Control (non-injured) 0.024 ± 0.003 0.025 ± 0.006 
4 hr (post injury) 0.060 ± 0.005 0.233 ± 0.035 
Day 3 (post injury) 0.102 ± 0.006 0.123 ± 0.029 
Day 7 (post injury) 0.101 ± 0.006 0.067 ± 0.014 
Day 14 (post injury) 0.025 ± 0.002 0.026 ± 0.005 
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Figure 3.13:  The number of M-cadherin+ satellite cells/myofibre 
 
Time point Placebo GSE 
Control (non-injured) 0.055 ± 0.002 0.048 ± 0.020 
4 hr (post injury) 0.285 ± 0.026 0.164 ± 0.040 
Day 3 (post injury) 0.018 ± 0.041 0.112 ± 0.024 
Day 7 (post injury) 0.076 ± 0.008 0.069 ± 0.024 
Day 14 (post injury) 0.029 ± 0.003 0.031 ± 0.008 
 
 
Figure 3.15:  Percentage of MHCf+ myofibres 
 
Time point Placebo GSE 
Control (non-injured) 0.00 ± 0.00  0.00 ± 0.00  
4 hr (post injury) 2.12 ± 1.34  7.78 ± 1.56  
Day 3 (post injury) 3.95 ± 1.79  13.2 ± 2.00  
Day 7 (post injury) 11.9 ± 2.25  3.93 ± 1.18  
Day 14 (post injury) 3.68 ± 1.28 2.52 ± 0.66  
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